WO2002088737A1 - Immunochromatographic test piece and diagnosis kit - Google Patents

Immunochromatographic test piece and diagnosis kit Download PDF

Info

Publication number
WO2002088737A1
WO2002088737A1 PCT/JP2002/004011 JP0204011W WO02088737A1 WO 2002088737 A1 WO2002088737 A1 WO 2002088737A1 JP 0204011 W JP0204011 W JP 0204011W WO 02088737 A1 WO02088737 A1 WO 02088737A1
Authority
WO
WIPO (PCT)
Prior art keywords
antibody
carrier
colored latex
antigen
buffer
Prior art date
Application number
PCT/JP2002/004011
Other languages
French (fr)
Japanese (ja)
Inventor
Seigo Nakaya
Masami Sato
Hirofumi Kajiyama
Haruhisa Hirata
Original Assignee
Wakamoto Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co., Ltd. filed Critical Wakamoto Pharmaceutical Co., Ltd.
Priority to JP2002585986A priority Critical patent/JP4443117B2/en
Publication of WO2002088737A1 publication Critical patent/WO2002088737A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56922Campylobacter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody

Definitions

  • the present invention relates to an oral matography test strip and a diagnostic kit.
  • Helicobacter pylori is a bacterium found in human gastric mucosa.
  • the infection rate of Helicobacter pylori is closely related to the socio-economic status, with the infection rate tending to be higher in developing countries and lower in developed countries, but is lower in Japanese people. It is by far the highest among developed countries, with 80% of those over the age of 40 reportedly infected. In recent years, it has become clear that Helicobacter pylori can cause various gastric and duodenal diseases such as gastric ulcer, duodenal ulcer, chronic gastritis, and even gastric cancer.
  • Helicobacter pylori eradication has been shown to reduce the likelihood of developing these diseases, and there has been international debate on the possible eradication of Helicobacter pylori.
  • duodenal ulcer, gastric malignant lymphoma, and stomach after early gastric cancer resection are recognized as applicable indications for eradication.
  • the Japanese Society of Gastroenterology has created clinical trial guidelines in Japan and diagnosed the presence of Helicobacter pylori infection. (Journal of the Japanese Society of Gastroenterology, Vol. 96, 199—207, 199).
  • the diagnosis of presence is performed by culture, microscopy, and urease tests of gastric biopsy tissue, which are invasive tests, and eradication is determined by culture and microscopy of gastric biopsy tissue. It has been shown that a urea breath test, a non-invasive test, is required. In addition, it has been shown that in special cases, such as when the subject is a child, the determination is made using blood anti-Helicobacter pylori antibody test and presence diagnosis in combination.
  • Invasive testing is a method in which the subject suffers a great deal of pain due to insertion of a gastroscope and biopsy. I will be able to.
  • Non-invasive testing significantly improves the patient's pain
  • urea breath testing requires fasting before testing.
  • the urea breath test requires devices such as a mass spectrum and an infrared spectrometer, and can be performed only in a specific facility, and has the disadvantage of increasing costs.
  • Antibody testing is not suitable for eradication determination because the blood antibody titer remains high for a long time even after eradication. Therefore, there is a demand for a non-invasive and a method for directly and specifically detecting Helicobacter pylori infection that can accurately and accurately detect Helicobacter pylori infection.
  • an object of the present invention is to provide an immunochromatographic test strip and a diagnostic kit which can determine infection to Helicobacter pylori with high sensitivity using feces as a specimen. is there.
  • a carrier for holding a colored latex label and a carrier for absorbing a liquid sample composed of filter paper are laminated in order from the bottom on the lower end of the strip-shaped antibody-immobilized support
  • a test piece for immunochromatography comprising a laminate in which a water-absorbing carrier made of filter paper is laminated on the upper end of a body, wherein the antibody-immobilized support is a helicobacter pylori on a dinitrocellulose sheet.
  • a monoclonal antibody that performs an antigen-antibody reaction with the native force tarase of the present invention is immobilized.
  • the carrier holding the labeled latex particle label is a helicopter. Immobilized non-woven fabric with colored latex particle-labeled anti-Helicobacter pylori antibody immobilized with monoclonal antibody A chromatography specimen.
  • the immunochromatography one test piece of the present invention comprises, in order from the bottom, a carrier for holding a colored latex label, and a carrier for absorbing a liquid sample composed of filter paper on the lower end of the strip-shaped antibody-immobilized support, On the other hand, it comprises a laminate in which a water-absorbing carrier made of filter paper is laminated on the upper end of the antibody-immobilized support.
  • the antibody-immobilized support is obtained by immobilizing a monoclonal antibody (hereinafter also referred to as an anti-Hp monoclonal antibody) that performs an antigen-antibody reaction with a native catalase of Helicobacter pylori on a nitrocellulose sheet. Is what it is.
  • a monoclonal antibody hereinafter also referred to as an anti-Hp monoclonal antibody
  • anti-Hp monoclonal antibody examples include Hypridoma 21G2 (FERM BP-7337), 41A5 (FERM BP-7337), or 82B9 (FERM BP-7338), 31A3 (FERM P-18329) Or a monoclonal antibody produced from 82A3 (FERM P-18328).
  • the immobilized anti-Hp monoclonal antibody recognizes Helicobacter pylori catalase in the sample and can capture a complex of catalase and colored latex particle-labeled anti-Helicobacter pylori antibody. Therefore, if the anti-Hp monoclonal antibody is immobilized on a line on the antibody-immobilized support, the line will be raised by the colored latex particles.
  • the antibody-immobilized support can be obtained by applying a buffer in which an anti-Hp monoclonal antibody is dispersed to a nitrocellulose sheet and drying.
  • the buffer is not particularly limited, but sodium acetate buffer, ammonium acetate buffer, sodium phosphate buffer and the like are preferable from the viewpoint of the detection sensitivity of Hemobacter pylori in the obtained immunochromatographic test piece.
  • an antibody against the anti-Hp monoclonal antibody, a catalase of Helicobacter pylori, and a substance that specifically binds to the labeled latex particles for control lines are immobilized on the antibody-immobilized support. It may be. This makes it possible to determine whether or not the immunochromatography test has been performed normally.
  • the colored latex particle-labeled substance holding carrier includes a colored latex particle-labeled anti-Helicobacter pylori antibody formed by immobilizing a monoclonal antibody that performs an antigen-antibody reaction with the native catalase of Helicobacter pylori on the colored latex particles. It is impregnated in nonwoven fabric.
  • the nonwoven fabric is not particularly limited, and examples thereof include those made of polyester, rayon, polypropylene, cellulose, pulp, and the like.
  • the latex particles are not particularly limited.
  • homopolymers or copolymers of vinyl / vinyl monomers such as styrene, butyl chloride, acrylonitrile, butyl acetate, acrylates and methacrylates; styrene-butadiene copolymer Fine particles obtained by coloring a polymer, a butadiene-based copolymer such as a methyl methacrylate-butadiene copolymer, and the like can be given.
  • polystyrene-based latex particles are preferably used because they have excellent adsorptivity for antibodies or antigens and can maintain biological activity stably for a long period of time.
  • a method for supporting an anti-Hp monoclonal antibody on the above colored latex particles is as follows. There is no particular limitation, and for example, it can be carried out by a method of physically or chemically adsorbing.
  • the colored latex particle labeled substance holding carrier may further be impregnated with a second colored latex particle labeled substance in which an antibody or the like is immobilized on a colored latex colored in a different color.
  • a labeled second colored latex particle can be used as a control line tool.
  • the colored latex particle labeled substance holding carrier is preferably blocked with skim milk or pepsin albumin. This makes it possible to suppress non-specific reactions and eliminate false positives in which a negative sample is determined to be positive.
  • the liquid sample-absorbing carrier preferably has an acidic substance-adsorbing ability. . Pigments and impurities in feces are often acidic. By retaining the ability to adsorb acidic substances, it is possible to exhibit excellent detection sensitivity and specificity for Helicobacter and H. pylori.
  • the liquid sample-absorbing carrier having such an acidic substance-adsorbing ability a commercially available product can be used, and for example, DE81 (manufactured by Whatman) and the like can be mentioned.
  • the immunochromatographic test piece of the present invention may be further fixed to a substrate made of plastic or the like to have strength, or may be provided with a transparent tape or the like on the surface for protection. .
  • the method for producing the immunochromatographic test strip of the present invention is not particularly limited, and can be obtained, for example, by the following method.
  • Red latex particle dispersion (PL-Latex, 10%, 450 nm, manufactured by Polymer Laboratories) 1.2 mL of PBS was added to 300 juL, and centrifuged at 13000 rpm for 5 minutes. .
  • centrifugation was performed at 13000 rpm for 5 minutes, and the precipitate was suspended in 1.5 mL of PBS and centrifuged again.
  • Masking was performed by adding 1 mL of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, the mixture was centrifuged at 13000 rpm for 5 minutes, and the precipitate was suspended in 1.5 mL of PBS containing 1% skim mill Cou 0.01% sodium azide.
  • blue latex particle dispersion (PL-Late III, 10%, 450 nm, manufactured by Polymer Laboratories) and egret IgG (0.5 mg / ml, manufactured by Cappel)
  • PL-Late III 10%, 450 nm, manufactured by Polymer Laboratories
  • egret IgG 0.5 mg / ml, manufactured by Cappel
  • Equal amounts of the above two types of colored latex particle-labeled antibodies were mixed, impregnated with 10 ⁇ L of a 5 mm ⁇ 5 mm nonwoven fabric (registered trademark) (trademark), and dried by ventilation.
  • the carrier holding the colored latex label was stacked up to 2.5 mm from the lower end of the antibody-immobilized support. Furthermore, a liquid sample absorbing carrier (3 MM Chr, manufactured by Whatman) was placed on the colored latex label holding carrier to a position 2.5 mm from the lower end. In addition, a water-absorbing carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support, and finally a transparent tape is attached to the top and fixed, and the immunochromatography test piece is fixed. And
  • a diagnostic kit including the immunochromatographic test strip of the present invention is also one of the present invention.
  • the diagnostic kit includes, in addition to the immunochromatographic test strip of the present invention, for example, a well, a positive control, a negative control, a stool suspension buffer, a concentrated washing solution, and the like may be included.
  • the stool suspension buffer is not particularly limited, but PBS and sodium or sodium borate buffer are preferred in view of excellent detection sensitivity.
  • a nitrocellulose sheet (manufactured by Whatman) was cut into 5 mm x 2 Omm, and an anti-Hp monoclonal antibody 21G2 solution prepared with each buffer for test lines was placed at a position 10 mm from the lower end, and a position 15 mm from the bottom. Then, an anti-mouse IgG polyclonal antibody (Cappe 1) (lmg / mL) was applied linearly using Biojet Q3000 (Biodot) as a control line to immobilize it. After drying at room temperature for 2 hours, masking was performed by immersing in 1% skim milk (manufactured by Difco) -0.1% Tween 20-PBS for 10 minutes. Then, it was sufficiently dried.
  • a red latex particle dispersion (PL-Latex, 10%, particle diameter 450 nm, manufactured by Polymer Laboratories) was centrifuged at 10,000 rpm for 5 minutes.
  • An anti-Hp monoclonal antibody 21 G 2 solution (lmg / mL) was added to the precipitate, and the mixture was mixed well and reacted at room temperature for 1 hour. Unreacted monoclonal anti
  • centrifugation was performed at 10,000 rpm for 5 minutes, the precipitate was suspended in 1 mL of PBS, and centrifuged again.
  • Masking was performed by adding 1 mL of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in PBSlmL containing 1% skim milk and 0.01% sodium azide.
  • Helicobacter Pylori ATCC43504 strain was microaerobically cultured for 4 days at 37 ° C on 150 plates of Brain Heart Infusion Agar Medium (Diff Kone Soil) containing 5% permeabilized blood. After the culture, the cells were collected, suspended in 40 mL of PBS, and centrifuged at 300 rpm for 20 minutes. The precipitate was suspended in 4 OmL of PBS containing 0.5% formalin and inactivated by leaving it at 4 ° (:, 1 ⁇ . The inactivated cells were PBS
  • the cells were resuspended in the same amount of PBS. After confirming the turbidity of the bacterial solution (absorbance at 540 nm) and the total number of bacteria (microscopic observation using a calculator), the cells were disrupted by sonication. The disrupted cells were centrifuged at 3,000 rpm for 20 minutes, and the supernatant was further ultracentrifuged at 30,000 rpm for 30 minutes. The supernatant was filtered through a 0.2 ⁇ filter to obtain an Hp standard antigen.
  • a nitrocellulose sheet (made by Petman) was cut into a size of 5 mm x 20 mm, and an anti-Hp prepared with 10 mM ammonium acetate (pH 5) buffer containing 3% methanol for the test line at a position 1 Omm from the lower end.
  • a monoclonal antibody solution (1 mg / mL) and anti-mouse IgG polyclonal antibody (Cappe 1) (lmg / mL) (lmg / mL) as a control line at the position of 15 mni were added to BioDiet Q3000 (Biodot). It was applied linearly and solidified. After drying at room temperature for 2 hours, masking was performed by immersing in 1% skim milk (manufactured by Difco) -0.1% Tween 20-PBS for 10 minutes. Then, it was sufficiently dried.
  • the glass filter cut to 5 mm ⁇ 10 mm was immersed in PVA, PVP, Tween 20, Triton X-100, SDS, skim milk, and BSA adjusted to a concentration of 1% for 5 minutes each to perform blocking. After drying at room temperature for 2 hours, the colored latex particle-labeled antibody prepared in Example 1 was applied in an amount of 10 ⁇ L. After that, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
  • the respective colored latex-labeled antibody holding carriers prepared in (2) were overlapped to a position 2 mm from the lower end of the antibody-immobilized support prepared in (1).
  • a liquid sample absorption carrier (CZP_30, manufactured by Whatman) was placed on the colored latex holding carrier to a position 2.5 mm from the lower end.
  • a water-absorbent carrier (3 MM Chr, manufactured by Whatman) is placed 2 mm from the upper end of the antibody-immobilized support. And fix it on the top to make a chromatographic test piece.
  • Example 1 10 ⁇ L of the colored latex particle-labeled antibody prepared in 1) was applied. Thereafter, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
  • the carrier holding the colored latex label produced in (1) was overlapped with a position 2 mm from the lower end of the antibody-immobilized support produced in Example 2. Further, CZP-30 (manufactured by Petman), P81 (manufactured by Petman), C / DE 30 (manufactured by Petman), DE81 (manufactured by Whatman) are used as carriers for absorbing liquid samples on the colored latex-labeled carrier. ), GF / QA30 (manufactured by Whatman) was placed up to 2.5 mm from the lower end. In addition, a water-absorbent carrier (3MM Chr, manufactured by Petman) is placed up to 2 mm from the top of the antibody-immobilized support. did.
  • the colored latex-labeled substance holding carrier prepared in Example 3 was overlapped with a position 2 mm from the lower end of the antibody-immobilized support prepared in Example 2. Further, DE 81 (manufactured by Whatman) was superimposed on the carrier holding the colored latex label as a liquid sample absorbing carrier to a position 2.5 mm from the lower end. In addition, a water-absorbing carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support, and finally a transparent tape is stuck on top and immobilized. It was a piece. (2) Effect of stool suspension buffer composition on Hp standard antigen detection
  • Cappe 1 An anti-mouse IgG polyclonal antibody (Cappe 1) (lmg / mL) was applied linearly to a solid line by using Biojet Q3000 (Biodot) for a troll line. After drying at room temperature for 2 hours, it was immersed in 1% skim milk (manufactured by Difco) -0.1% Tween 20-PBS for 10 minutes to perform masking. Then, it was sufficiently dried. (2) Preparation of colored latex particle labeled antibody
  • Red latex particle dispersion (PL-Latex, 10%, particle diameter 450 nm, manufactured by Polymer Laboratories) lO O ⁇ L was centrifuged at 10,000 rpm for 5 minutes.
  • 1 mL of anti-Hp monoclonal antibody 82B9 solution (Img / mL) was added to the precipitate, mixed well, and reacted at room temperature for 1 hour.
  • centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in 1 mL of PBS and centrifuged again.
  • Masking was performed by adding 1 mL of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in PBSlmL containing 1% skim milk and 0.01% sodium azide.
  • the glass filter cut to 5 mm ⁇ 10 mm was immersed in skim milk adjusted to a concentration of 1% for 5 minutes to perform blocking. After drying at room temperature for 2 hours, one of the colored latex particle-labeled antibodies prepared in (2) was applied. Thereafter, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
  • the colored latex label holding material prepared in (3) was superimposed on the antibody-immobilized support prepared in (1) to a position 2 mm from the lower end of the support. Further, DE81 (made by Petman) as a carrier for absorbing a liquid sample was stacked on the carrier holding the colored latex label to a position 2.5 mm from the lower end. In addition, a water-absorbing carrier (3MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support, and finally a transparent tape is attached to the top and fixed, and the immobilized chromatographic test piece is attached. did.
  • a red latex particle dispersion (PL-Latex, 10%, particle diameter 450 nm, manufactured by Polymer Laboratories) was centrifuged at 10,000 rpm for 5 minutes.
  • 1 mL of anti-Hp monoclonal antibody 41A5 solution (lmg / mL) was added to the precipitate, mixed well, and reacted at room temperature for 1 hour.
  • centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in 1 mL of PBS and centrifuged again.
  • Masking was performed by adding 1 mL of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in PBS B containing 1% skim milk and 0.01% sodium azide.
  • the glass filter cut to 5 mm ⁇ 10 mm was immersed in skim milk adjusted to 1% concentration for 5 minutes to perform blocking. After drying at room temperature for 2 hours, 10 L of the colored latex particle-labeled antibody prepared in (2) was applied. Thereafter, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
  • the colored latex label holding material prepared in (3) was superimposed on the antibody-immobilized support prepared in (1) to a position 2 mm from the lower end of the support. Furthermore, DE81 (made by Petman) as a carrier for absorbing a liquid sample was superimposed on the carrier holding the colored latex label to a position 2.5 mm from the lower end. In addition, a water-absorbent carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support. And (5) Measurement of Hp antigen standard solution
  • the anti-Hp monoclonal antibody solution prepared in the above solution was placed at a position of 15 mm, and an anti-mouse IgG polyclonal antibody (manufactured by Cappe 1) (1 mg / m 1) was used as a control line for Biojet Q3000 (Biodot).
  • an anti-mouse IgG polyclonal antibody manufactured by Cappe 1 (1 mg / m 1) was used as a control line for Biojet Q3000 (Biodot).
  • Biojet Q3000 Biodot
  • masking was performed by immersing in 1% skim milk (manufactured by Difco) -0.1% Tween 20-; PBS for 10 minutes. Then, it was sufficiently dried.
  • the carrier holding the antibody 21G2 colored latex labeling substance prepared in Example 3 (1) was overlapped to a position 2 mm from the lower end of each of the antibody-immobilized supports prepared in (1). Further, DE 81 (manufactured by Whatman) as a carrier for absorbing a liquid sample was overlaid on the carrier holding the colored latex label to a position 2.5 mm from the lower end. In addition, a water-absorbing carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support. It was a piece.
  • An anti-mouse IgG polyclonal antibody (lm g / m 1) was applied linearly using a BioJet Q3000 (Biodot) to solidify it. After drying at room temperature for 2 hours, 1% skim milk (Difco ) —0.1% Tween 20—Passed for 10 minutes and masked. Then, it was sufficiently dried.
  • Red latex particle dispersion (PL-Late: 10%, particle diameter 450 nm, manufactured by Polymer Laboratories) lO O ⁇ L was centrifuged at 10,000 rpm for 5 minutes. 1 ml of anti-Hp monoclonal antibody 82A3 solution (lmg / ml) was added to the precipitate, mixed well, and reacted at room temperature for 1 hour. To remove unreacted monoclonal antibodies, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in 1 ml of PBS and centrifuged again. Masking was performed by adding 1 ml of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in PBS Ira 1 containing 1% skim milk and 0.01% sodium azide. (3) Preparation of carrier holding colored latex label
  • the glass filter cut to 5 mm 10 mm was immersed in skim milk adjusted to 1% concentration for 5 minutes to perform blocking. After drying at room temperature for 2 hours, the colored latex particle-labeled antibody prepared in (2) was applied in an amount of 10 ZL. Thereafter, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
  • the colored latex label holding material prepared in (3) was superimposed on the antibody-immobilized support prepared in (1) to a position 2 mm from the lower end of the support. Furthermore, DE81 (manufactured by Wattman) as a carrier for absorbing a liquid sample was overlaid on the carrier holding the colored latex label to a position 2.5 mm from the lower end. In addition, a water-absorbent carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support. And
  • a stool suspension using 15 OmM sodium borate (pH 8) shown in Example 4 was obtained by using 5 Omg of stool specimens of each of 10 subjects determined as Hp positive and negative by the urea breath test.
  • the suspension was suspended in 1 mL of a turbidity buffer.
  • the stool suspension 50 was used as the liquid for each test specimen prepared in Example 3 (using DE 81 as a carrier for liquid sample absorption), Example 5, Example 6, Example 7, and Example 8.
  • the solution was dropped onto the sample absorbing carrier.
  • Ten minutes later, the presence or absence of a red line on the test line was visually determined. As a result, in all of the test specimens, a red line was confirmed in all of the 10 positive specimens, and the specimen was determined to be positive.
  • a fecal sample (5 Omg) of 66 Hp-positive persons and 12 negative persons determined by the urea breath test was suspended in 1 mL of the stool suspension buffer using PBS shown in Example 4. 50 L of the stool suspension was dropped onto the liquid sample-absorbing carrier of the immunochromatography one test piece (DE 81 was used as the liquid sample-absorbing carrier) prepared in Example 3. After 10 minutes, the presence or absence of a red line on the test line was visually determined. As a result, a red line was confirmed in all 66 positive samples, and it was determined to be positive. On the other hand, in the negative samples, no red line was observed in all of the 12 cases, and the sample was judged to be negative and the concordance rate was 100%. The control line was confirmed for all samples.
  • Example 1 2 Reactivity to other strains was examined. Each strain was cultured in the same manner as described in Example 1 to collect cells, and the cells were sonicated to prepare Hp antigen. 0.5% BSA—50 ⁇ L of Hp antigen solution diluted to 0.25 ZmL with 15 OmM sodium borate buffer (pH 8) containing 0.02% Tween 20 was prepared in Example 3. A drop was dropped onto a liquid sample absorbing carrier of a munochromatographic test piece (DE81 was used as a liquid sample absorbing carrier). Ten After one minute, the presence or absence of a red line on the test line was visually determined. As a result, a red line was confirmed in all of the 120 clinically isolated Hp strains, and it was determined to be positive. The control line was confirmed for all samples. Example 1 2 Reactivity to other strains
  • the present invention has the above-described configuration, it is possible to provide an immunochromatography-one test strip and a diagnostic kit that can determine infection to Helicobacter pylori with high sensitivity using feces as a specimen.

Abstract

It is intended to provide an immunochromatographic test piece and a diagnosis kit whereby infection with Helicobacter pylori can be judged at a high sensitivity with the use of feces as specimens. An immunochromatographic test piece comprising a laminate composed of a rectangular antibody immobilized substrate which has, on its bottom end, a support holding a colored latex labeled-material and a liquid sample-absorbing support made of filter paper laminated thereon in the order from the bottom to the top, and on its top end, a water-absorbing support made of filter paper laminated thereon. In the antibody immobilized substrate, a monoclonal antibody undergoing an antigen-antibody reaction with native catalase of H. pylori is immobilized on a nitrocellulsoe sheet. In the support holding the colored latex particle labeled-material, nonwoven fabric is impregnated with a colored latex particle-labeled anti-H. pylori antibody wherein a monoclonal antibody undergoing an antigen-antibody reaction with native catalase of H. pylori is immobilized on colored latex particles.

Description

明細書  Specification
ィムノクロマトグラフィ一試験片及ぴ診断キット  Immunochromatography-one test strip and diagnostic kit
技術分野 Technical field
本発明は、 口マトグラフィー試験片及び診断キットに関する < 背景技術  TECHNICAL FIELD The present invention relates to an oral matography test strip and a diagnostic kit.
ヘリコバクタ一 ' ピロリ (He l i c o b a c t e r p y l o r i ) はヒ ト の胃粘膜に見られる細菌である。 へリコパクター · ピロリへの感染率は、 社会経 済状態と密接に関連しており、 発展途上国ほど感染率が高く、 先進国ほど感染率 が低くなる傾向があるが、 日本人の感染率は先進国の中でも際立って高く、 40 歳以上では 8 0%の人が感染しているとも言われている。 近年、 へリコパクター • ピロリが胃潰瘍、 十二指腸潰瘍、 慢性胃炎、 更には胃癌等のさまざまな胃、 十 二指腸疾患の原因となり うることが明らかになつてきた。  Helicobacter pylori is a bacterium found in human gastric mucosa. The infection rate of Helicobacter pylori is closely related to the socio-economic status, with the infection rate tending to be higher in developing countries and lower in developed countries, but is lower in Japanese people. It is by far the highest among developed countries, with 80% of those over the age of 40 reportedly infected. In recent years, it has become clear that Helicobacter pylori can cause various gastric and duodenal diseases such as gastric ulcer, duodenal ulcer, chronic gastritis, and even gastric cancer.
へリコパクター · ピロリを除菌することにより、 これらの疾患に罹患する可能 性を低減できることが明らかになったために、 へリコパクター ' ピロリの除菌対 象疾患について国際的な議論がなされ、 現在では胃潰瘍、 十二指腸潰瘍、 胃悪性 リンパ腫、 早期胃癌切除後胃等が除菌の適応対象疾患として認知 れている。 へリコパクター · ピロリの除菌療法が胃、 十二指腸疾患の新しい治療法として 認、知されるのに伴い、 我が国でも日本消化器病学会により治験ガイドラインが作 成され、 へリコパクター · ピロリ感染の存在診断と除菌判定法が示された (日本 消化器病学会雑誌、 9 6卷、 1 9 9— 20 7、 1 9 9 9年) 。 上記治験ガイドラ インでは、 存在診断は侵襲的検査法である胃部生検糸且織の培養、 鏡検、 ゥレアー ゼ試験にて行い、 除菌判定は胃部生検組織の培養と鏡検及び非侵襲的検査法であ る尿素呼気試験を必須とすることが示されている。 また、 被験者が小児である等 の特殊な場合、 血中抗へリコパクター ·ピロリ抗体検査と存在診断とを併用して 判定を行うことが示されている。  Helicobacter pylori eradication has been shown to reduce the likelihood of developing these diseases, and there has been international debate on the possible eradication of Helicobacter pylori. In addition, duodenal ulcer, gastric malignant lymphoma, and stomach after early gastric cancer resection are recognized as applicable indications for eradication. With the recognition and recognition of Helicobacter pylori eradication therapy as a new treatment for gastric and duodenal diseases, the Japanese Society of Gastroenterology has created clinical trial guidelines in Japan and diagnosed the presence of Helicobacter pylori infection. (Journal of the Japanese Society of Gastroenterology, Vol. 96, 199—207, 199). According to the above guidelines, the diagnosis of presence is performed by culture, microscopy, and urease tests of gastric biopsy tissue, which are invasive tests, and eradication is determined by culture and microscopy of gastric biopsy tissue. It has been shown that a urea breath test, a non-invasive test, is required. In addition, it has been shown that in special cases, such as when the subject is a child, the determination is made using blood anti-Helicobacter pylori antibody test and presence diagnosis in combination.
し力 し、 これらのへリコパクター . ピロリ感染の検查法には以下の問題点があ る。 侵襲的検查法は、 胃内視鏡の挿入及び生検等により被験者が多大な苦痛を強 いられることとなる。 非侵襲的検査法では、 被験者の苦痛は大幅に改善されるが、 尿素呼気試験では、 検查前の絶食が必要である。 また、 尿素呼気試験は、 マスス ぺクトルや赤外分光高度計等の装置が必要であり、 特定の施設でしか実施できず、 コス トも高くなるという欠点がある。 抗体検查は、 除菌後も血中抗体価が長期に わたり高値であるので、 除菌判定には適さない。 従ってこれらの検査に代わる、 非侵襲的で且つへリコパクター ·ピロリ感染を直接、 特異的に精度良く検出でき る検查方法が望まれている。 However, these methods for detecting Helicobacter pylori infection have the following problems. Invasive testing is a method in which the subject suffers a great deal of pain due to insertion of a gastroscope and biopsy. I will be able to. Non-invasive testing significantly improves the patient's pain, whereas urea breath testing requires fasting before testing. In addition, the urea breath test requires devices such as a mass spectrum and an infrared spectrometer, and can be performed only in a specific facility, and has the disadvantage of increasing costs. Antibody testing is not suitable for eradication determination because the blood antibody titer remains high for a long time even after eradication. Therefore, there is a demand for a non-invasive and a method for directly and specifically detecting Helicobacter pylori infection that can accurately and accurately detect Helicobacter pylori infection.
従来、 消化管感染菌の直接検査法として消化管排泄物、 特に糞便からの感染菌 の選択培地を用いた分離培養が行われてきた。 しかし、 ヘリコバクタ一 .ピロリ に関しては数多くの試みにも拘らず、 糞便から分離培養された報告はほとんどな い。 その理由として、 ヘリコパクター 'ピロリは i n v i t r oで、 低温、 栄 養欠乏、 酸素欠乏等のように環境条件が悪化すると、 通常のらせん状体から培養 不能な球状体へ形態変化することから、 下部消化管においても分離培養不能な球 状体に変化していることが考えられる。  Conventionally, as a direct test method for infectious bacteria in the gastrointestinal tract, separation culture using a selective medium for infectious bacteria from gastrointestinal excreta, particularly feces, has been performed. However, there have been few reports of Helicobacter pylori isolated and cultured from feces, despite numerous attempts. The reason for this is that Helicobacter pylori is in vitro, and when environmental conditions such as low temperature, nutrient deficiency, and oxygen deficiency deteriorate, the morphology changes from a normal spiral to a non-cultureable spheroid, and It is also conceivable that the spheres have changed to spheres that cannot be separated and cultured.
一方、 抗原抗体反応に基づく免疫学的方法による糞便からのへリコパクター · ピロリの直接検出に関して、 へリコパクター ' ピロリに対するポリクローナル抗 体を用いたィムノアッセィにより糞便等の排泄物検体中のヘリコパクター ·ピロ リを検出する方法が報告されている (J. C 1 i n. M i c r o b i o l . 、 3 3卷、 2162— 21 65、 1 995年、 特開平 10— 10128号公報 (特許 第 3043999号) ) 。  On the other hand, regarding the direct detection of Helicobacter pylori from feces by an immunological method based on an antigen-antibody reaction, helicobacter pylori in feces and other excrement samples was analyzed by immunoassay using a polyclonal antibody against Helicobacter pylori. A detection method has been reported (J. C. inn. Microbiol., Vol. 33, 2162-2165, 1995, JP-A-10-10128 (Patent No. 3043999)).
し力 し、 ポリクローナル抗体は、 一般に交差反応性があり、 特異性が劣るうえ、 抗血清の口ット毎に抗体価や特異性が変動する欠点があるので、 ポリクローナル 抗体を用いた診断薬の製造は、 本質的に品質管理が難しいという問題点がある。 現実に、 特許第 3043999号の特許権者であるメリディアン社により製造さ れたポリクローナル抗体を用いた糞便中ヘリコパクター ·ピロリ抗原検出キット 「Hp SA」 に関しては、 偽陰性の出現や特異性の低さが問題となっている (M e d i c a l T r i b u n e、 4— 5、 1999年 6月 3日号; Am. J. G a s t r o e n t e r o l . 、 94卷、 1 830— 1 833、 1999年) 。 発明の要約 However, polyclonal antibodies generally have cross-reactivity, are poor in specificity, and have the disadvantage that the antibody titer and specificity fluctuate with each antiserum. Manufacturing has the problem that quality control is inherently difficult. In fact, the stool Helicobacter pylori antigen detection kit `` Hp SA '' using polyclonal antibodies manufactured by Meridian, Inc., the patent holder of Patent No. 3043999, has false negatives and low specificity. (Medical Tribune, 4-5, June 3, 1999; Am. J. Gastroenterol., Vol. 94, 1830-1833, 1999). Summary of the Invention
本発明は、 上記現状に鑑み、 糞便を検体として用い、 感度よくへリコパクター • ピロリへの感染を判定することができるィムノクロマトグラフィー試験片及ぴ 診断キットを提供することを目的とするものである。  In view of the above situation, an object of the present invention is to provide an immunochromatographic test strip and a diagnostic kit which can determine infection to Helicobacter pylori with high sensitivity using feces as a specimen. is there.
本発明は、 短冊形状の抗体固相化支持体の下端上に下から順に着色ラテックス 標識物保持担体、 及び、 濾紙からなる液体試料吸収用担体が積層され、 一方、 前 記抗体固相化支持体の上端上に濾紙よりなる吸水性担体が積層されてなる積層体 からなるィムノクロマトグラフィ一試験片であって、 前記抗体固相化支持体は、 二トロセルロースシ一ト上にヘリコパクター . ピロリのネイティブな力タラーゼ と抗原抗体反応を行うモノクローナル抗体が固相化されてなり、 前記着色ラテツ クス粒子標識物保持担体は、 着色ラテックス粒子にへリコパクター . ピロリのネ ィティブな力タラーゼと抗原抗体反応を行うモノク口ーナル抗体を固定化してな る着色ラテックス粒子標識抗ヘリコパクター · ピロリ抗体が不織布に含浸されて なるィムノクロマトグラフィー試験片である。 発明の詳細な開示  In the present invention, a carrier for holding a colored latex label and a carrier for absorbing a liquid sample composed of filter paper are laminated in order from the bottom on the lower end of the strip-shaped antibody-immobilized support, A test piece for immunochromatography comprising a laminate in which a water-absorbing carrier made of filter paper is laminated on the upper end of a body, wherein the antibody-immobilized support is a helicobacter pylori on a dinitrocellulose sheet. A monoclonal antibody that performs an antigen-antibody reaction with the native force tarase of the present invention is immobilized. The carrier holding the labeled latex particle label is a helicopter. Immobilized non-woven fabric with colored latex particle-labeled anti-Helicobacter pylori antibody immobilized with monoclonal antibody A chromatography specimen. Detailed Disclosure of the Invention
以下に本発明を詳述する。  Hereinafter, the present invention will be described in detail.
本発明のィムノクロマトグラフィ一試験片は、 短冊形状の抗体固相化支持体の 下端上に下から順に着色ラテックス標識物保持担体、 及ぴ、 濾紙からなる液体試 料吸収用担体が積層され、 一方、 前記抗体固相化支持体の上端上に濾紙よりなる 吸水性担体が積層されてなる積層体からなるものである。  The immunochromatography one test piece of the present invention comprises, in order from the bottom, a carrier for holding a colored latex label, and a carrier for absorbing a liquid sample composed of filter paper on the lower end of the strip-shaped antibody-immobilized support, On the other hand, it comprises a laminate in which a water-absorbing carrier made of filter paper is laminated on the upper end of the antibody-immobilized support.
上記抗体固相化支持体は、 ニトロセルロースシート上にヘリコパクター . ピロ リのネィティブなカタラ一ゼと抗原抗体反応を行うモノク口ーナル抗体 (以下、 抗 Hpモノクローナル抗体ともいう) が固相化されているものである。  The antibody-immobilized support is obtained by immobilizing a monoclonal antibody (hereinafter also referred to as an anti-Hp monoclonal antibody) that performs an antigen-antibody reaction with a native catalase of Helicobacter pylori on a nitrocellulose sheet. Is what it is.
上記抗 Hpモノクローナル抗体としては、 例えば、 ハイプリ ドーマ 21 G2 ( FERM BP— 7336) 、 41A5 (FERM B P- 7337) 、 又は、 82 B 9 (FERM BP— 7338) 、 31 A3 (FERM P- 18329 ) 、 又は、 82A3 (FERM P— 18328) から産生されるモノクロ ナ ル抗体を挙げることができる。 固相化された抗 H pモノクローナル抗体は、 検体中のへリコパクター ·ピロリ のカタラーゼを認識し、 カタラーゼと着色ラテックス粒子標識抗ヘリコパクター . ピロリ抗体との複合体を捕捉することができる。 従って、 抗 H pモノクローナ ル抗体が抗体固相化支持体上に線上に固相化されていれば、 そのラインが着色ラ テックス粒子により浮かび上がることとなる。 Examples of the anti-Hp monoclonal antibody include Hypridoma 21G2 (FERM BP-7337), 41A5 (FERM BP-7337), or 82B9 (FERM BP-7338), 31A3 (FERM P-18329) Or a monoclonal antibody produced from 82A3 (FERM P-18328). The immobilized anti-Hp monoclonal antibody recognizes Helicobacter pylori catalase in the sample and can capture a complex of catalase and colored latex particle-labeled anti-Helicobacter pylori antibody. Therefore, if the anti-Hp monoclonal antibody is immobilized on a line on the antibody-immobilized support, the line will be raised by the colored latex particles.
上記抗体固相化支持体は、 抗 H pモノクローナル抗体を分散させた緩衝液を、 ニトロセルロースシートに塗布し、 乾燥することにより得ることができる。  The antibody-immobilized support can be obtained by applying a buffer in which an anti-Hp monoclonal antibody is dispersed to a nitrocellulose sheet and drying.
上記緩衝液としては特に限定されないが、 得られたィムノクロマトグラフィー 試験片のヘリコパクター ·ピロリの検出感度の点から、 酢酸ナトリゥム緩衝液、 酢酸ァンモユウム緩衝液、 リン酸ナトリウム緩衝液等が好ましい。  The buffer is not particularly limited, but sodium acetate buffer, ammonium acetate buffer, sodium phosphate buffer and the like are preferable from the viewpoint of the detection sensitivity of Hemobacter pylori in the obtained immunochromatographic test piece.
上記抗体固相化支持体には、 更に、 抗 H pモノクローナル抗体に対する抗体、 へリ コパクター . ピロリのカタラーゼ、 コントロールライン用着色ラテックス粒 子標識物に対して特異的に結合する物質が固相化されていてもよい。 これにより、 ィムノクロマトグラフィ一試験が正常に行われたかどうかを判定することができ る。  Further, an antibody against the anti-Hp monoclonal antibody, a catalase of Helicobacter pylori, and a substance that specifically binds to the labeled latex particles for control lines are immobilized on the antibody-immobilized support. It may be. This makes it possible to determine whether or not the immunochromatography test has been performed normally.
上記着色ラテックス粒子標識物保持担体は、 着色ラテックス粒子にヘリコバク ター 'ピロリのネィティブなカタラーゼと抗原抗体反応を行うモノクロ一ナル抗 体を固定ィ匕してなる着色ラテックス粒子標識抗ヘリコパクター · ピロリ抗体が不 織布に含浸されているものである。  The colored latex particle-labeled substance holding carrier includes a colored latex particle-labeled anti-Helicobacter pylori antibody formed by immobilizing a monoclonal antibody that performs an antigen-antibody reaction with the native catalase of Helicobacter pylori on the colored latex particles. It is impregnated in nonwoven fabric.
上記不織布としては特に限定されず、 例えば、 ポリエステル、 レーヨン、 ポリ プロピレン、 セルロース、 パルプ等からなるものを挙げることができる。  The nonwoven fabric is not particularly limited, and examples thereof include those made of polyester, rayon, polypropylene, cellulose, pulp, and the like.
上記ラテックス粒子としては特に限定されず、 例えば、 スチレン、 塩化ビュル、 アクリロニトリル、 酢酸ビュル、 アクリル酸エステル、 メタクリル酸エステル等 のビ二/レ系モノマーの単一重合体や共重合体; スチレン一ブタジエン共重合体、 メチルメタタリレート一ブタジエン共重合体等のブタジエン系共重合体等に着色 してなる微粒子を挙げることができる。 これらのうち、 抗体又は抗原の吸着性に 優れており、 かつ、 生物学的活性を長期間安定に保持できる等の理由から、 ポリ スチレン系のラテックス粒子が好適に用いられる。  The latex particles are not particularly limited. For example, homopolymers or copolymers of vinyl / vinyl monomers such as styrene, butyl chloride, acrylonitrile, butyl acetate, acrylates and methacrylates; styrene-butadiene copolymer Fine particles obtained by coloring a polymer, a butadiene-based copolymer such as a methyl methacrylate-butadiene copolymer, and the like can be given. Of these, polystyrene-based latex particles are preferably used because they have excellent adsorptivity for antibodies or antigens and can maintain biological activity stably for a long period of time.
抗 H pモノクローナル抗体を上記着色ラテックス粒子に担持する方法としては 特に限定されず、 例えば、 物理的又は化学的に吸着させる方法等により行うこと ができる。 A method for supporting an anti-Hp monoclonal antibody on the above colored latex particles is as follows. There is no particular limitation, and for example, it can be carried out by a method of physically or chemically adsorbing.
上記着色ラテックス粒子標識物保持担体には、 更に、 異なる色に着色された着 色ラテックスに抗体等を固定した第 2着色ラテックス粒子標識物が含浸されてい てもよレ、。 このような第 2着色ラテックス粒子標識物はコントロールライン用マ 一力一として用いることができる。  The colored latex particle labeled substance holding carrier may further be impregnated with a second colored latex particle labeled substance in which an antibody or the like is immobilized on a colored latex colored in a different color. Such a labeled second colored latex particle can be used as a control line tool.
上記着色ラテツクス粒子標識物保持担体は、 スキムミルク又はゥシ血清アルブ ミンでブロッキングされていることが好ましい。 これにより、 非特異的な反応を 抑制することができ、 陰性の検体を陽性と判定する偽陽性をなくすことができる 上記液体試料吸収用担体は、 酸性物質吸着能を保持していることが好ましい。 糞便中の色素や夾雑物は酸性物質が多い。 酸性物質吸着能が保持されていること により、 へリコパクター · ピロリに対して優れた検出感度 ·特異度を発現するこ とができる。 このような酸性物質吸着能が保持されている液体試料吸収用担体と しては、 市販品を用いることができ、 例えば、 DE 81 (ワットマン社製) 等を 挙げることができる。  The colored latex particle labeled substance holding carrier is preferably blocked with skim milk or pepsin albumin. This makes it possible to suppress non-specific reactions and eliminate false positives in which a negative sample is determined to be positive. The liquid sample-absorbing carrier preferably has an acidic substance-adsorbing ability. . Pigments and impurities in feces are often acidic. By retaining the ability to adsorb acidic substances, it is possible to exhibit excellent detection sensitivity and specificity for Helicobacter and H. pylori. As the liquid sample-absorbing carrier having such an acidic substance-adsorbing ability, a commercially available product can be used, and for example, DE81 (manufactured by Whatman) and the like can be mentioned.
本発明のィムノクロマトグラフィー試験片は、 更に、 プラスチック等よりなる 基体に固定されて強度が付与されていてもよく、 また、 保護のために表面に透明 なテープ等が貼られていてもよい。  The immunochromatographic test piece of the present invention may be further fixed to a substrate made of plastic or the like to have strength, or may be provided with a transparent tape or the like on the surface for protection. .
本発明のィムノクロマトグラフィー試験片の製造方法としては特に限定されず、 例えば、 以下の方法により得ることができる。  The method for producing the immunochromatographic test strip of the present invention is not particularly limited, and can be obtained, for example, by the following method.
(1) 抗体固相化支持体の作製  (1) Preparation of antibody-immobilized support
抗 Hpモノクローナル抗体及ぴ抗ゥサギ I g G抗体を線状に固相化した抗体固 相化支持体を作製するために、 ニトロセルロースシート (ワットマン社製) を 5 mmX 2 Ommに裁断し、 その下端より 10 mmの位置にモノクローナル抗体 2 1G2の溶液、 15mmの位置に抗ゥサギ I g Gャギポリクローナル抗体 (C a p p e 1社製) の溶液をバイオジエツト Q3000 (B i o d o t社製) を用い て塗布した。 室温で 2時間乾燥後、 1%スキムミルク (D i f c o社製) -0. 1%ツイ一ン 20— PB Sに 10分浸漬しマスキングを行った。 その後、 充分に 乾燥した。 (2) 着色ラテックス粒子標識物保持担体の調製 In order to prepare an antibody-immobilized support in which an anti-Hp monoclonal antibody and an anti-magpie IgG antibody were linearly immobilized, a nitrocellulose sheet (manufactured by Whatman) was cut into 5 mm X 2 Omm, and A solution of monoclonal antibody 2 1G2 was applied at a position 10 mm from the lower end, and a solution of anti-Egret IgG goat polyclonal antibody (Cappe 1) was applied at a position 15 mm using Biojet Q3000 (Biodot). . After drying at room temperature for 2 hours, masking was performed by immersing in 1% skim milk (manufactured by Difco) -0.1% Tween 20-PBS for 10 minutes. Then, it was sufficiently dried. (2) Preparation of carrier holding colored latex particle label
a . 赤色ラテックス粒子標識抗ヘリコパクター ·ピロリ抗体  a. Red latex particle labeled anti-Helicobacter pylori antibody
赤色ラテックス粒子分散液 (PL— L a t e x、 10%、 450 n m、 P o l y me r L a b o r a t o r i e s社製) 300 ju Lに PB S 1. 2mLをカロ え、 13000 r pm、 5分間遠心分離を行った。 沈渣にモノクローナル抗体 2 1 G 2溶液 (5mgZmL) 1. 5mLをカロえ、 充分混和して、 室温、 1時間反 応を行った。 未反応のモノクローナル抗体を除去するため、 13000 r pm、 5分間遠心分離を行い、 沈渣を PB S 1. 5mLに懸濁し、 再度遠心分離を行つ た。 1%スキムミルク lmLを加え、 室温、 1時間反応させてマスキングを行つ た。 その後、 1 3000 r pm、 5分間遠心分離を行い、 沈渣を 1%スキムミル クー 0. 01 %アジ化ナトリウムを含む P B S 1. 5mLに懸濁した。  Red latex particle dispersion (PL-Latex, 10%, 450 nm, manufactured by Polymer Laboratories) 1.2 mL of PBS was added to 300 juL, and centrifuged at 13000 rpm for 5 minutes. . 1.5 mL of a monoclonal antibody 21 G2 solution (5 mg ZmL) was added to the precipitate, mixed well, and reacted at room temperature for 1 hour. To remove unreacted monoclonal antibody, centrifugation was performed at 13000 rpm for 5 minutes, and the precipitate was suspended in 1.5 mL of PBS and centrifuged again. Masking was performed by adding 1 mL of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, the mixture was centrifuged at 13000 rpm for 5 minutes, and the precipitate was suspended in 1.5 mL of PBS containing 1% skim mill Cou 0.01% sodium azide.
b. 青色ラテックス粒子標識ゥサギ I gG b. Blue latex particle labeling egret IgG
青色ラテックス粒子分散液 (P L— L a t e χ、 10%、 450 nm、 P o l y m e r L a b o r a t o r i e s社製) 及ぴゥサギ I gG (0. 5 m g /m L、 C a p p e l社製) を用いて上記と同様な操作で青色ラテックス粒子標識ゥ サギ I gGを調製した。  Same as above using blue latex particle dispersion (PL-Late III, 10%, 450 nm, manufactured by Polymer Laboratories) and egret IgG (0.5 mg / ml, manufactured by Cappel) By using a simple operation, blue latex particle-labeled rabbits IgG was prepared.
c 着色ラテックス粒子標識物保持担体 c Colored latex particle label carrier
上記 2種類の着色ラテックス粒子標識抗体を等量混和し、 ベンリーゼ (商標登 録) 不織布 (旭化成社製) 5mmX 5mmに 10 μ L含浸させ、 通風乾燥した。  Equal amounts of the above two types of colored latex particle-labeled antibodies were mixed, impregnated with 10 μL of a 5 mm × 5 mm nonwoven fabric (registered trademark) (trademark), and dried by ventilation.
(3) ィムノクロマトグラフィー試験片の作製  (3) Preparation of test piece for immunochromatography
抗体固相化支持体の下端から 2. 5 mmの位置まで着色ラテックス標識物保持 担体を重ねた。 更に、 着色ラテックス標識物保持担体上に液体試料吸収用担体 ( 3 MM Ch r、 ワットマン社製) を下端から 2. 5 mmの位置まで重ねた。 ま た、 抗体固相化支持体の上端から 2 mmの位置まで吸水性担体 ( 3 MM C h r、 ワットマン社製) を重ね、 最後に透明なテープを上部に貼り固定してィムノクロ マトグラフィ一試験片とした。  The carrier holding the colored latex label was stacked up to 2.5 mm from the lower end of the antibody-immobilized support. Furthermore, a liquid sample absorbing carrier (3 MM Chr, manufactured by Whatman) was placed on the colored latex label holding carrier to a position 2.5 mm from the lower end. In addition, a water-absorbing carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support, and finally a transparent tape is attached to the top and fixed, and the immunochromatography test piece is fixed. And
本発明のィムノクロマトグラフィー試験片が含まれている診断キットもまた、 本発明の 1つである。  A diagnostic kit including the immunochromatographic test strip of the present invention is also one of the present invention.
上記診断キットには、 本発明のィムノクロマトグラフィー試験片以外に、 例え ば、 ゥエル、 陽性コントロール、 陰性コントロール、 便懸濁用緩衝液、 濃縮洗浄 液等が含まれていてもよい。 The diagnostic kit includes, in addition to the immunochromatographic test strip of the present invention, For example, a well, a positive control, a negative control, a stool suspension buffer, a concentrated washing solution, and the like may be included.
上記便懸濁用緩衝液としては特に限定されないが、 検出感度に優れる点より、 P B S及ぴノ又はホウ酸ナトリゥム緩衝液が好ましい。 発明を実施するための最良の形態  The stool suspension buffer is not particularly limited, but PBS and sodium or sodium borate buffer are preferred in view of excellent detection sensitivity. BEST MODE FOR CARRYING OUT THE INVENTION
以下に実施例を掲げて本発明を更に詳しく説明するが、 本発明はこれら実施例 のみに限定されるものではない。  Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to only these Examples.
(実施例 1 ) 抗体固相化用緩衝液の検討  (Example 1) Examination of buffer solution for immobilizing antibody
(1) 抗体固相化支持体の作製  (1) Preparation of antibody-immobilized support
3%メタノールを含む 1 OmMの各緩衝液 (リン酸ナトリウム (pH5〜8) 、 酢酸ナトリウム (pH4〜6) 、 酢酸アンモニゥム (PH4〜6) 、 タエン酸ナ トリウム (pH4〜6) 、 トリス塩酸 (pH7〜9) 、 ホウ酸ナトリウム (pH 8— 10) 、 塩化アンモユウム (pH8〜l l) 、 炭酸アンモニゥム (pH8〜 10) ) を調製し、 抗ヘリコパクター ·ピロリ (Hp) モノクローナル抗体 21 G 2を lmg/mLの濃度に添加した。 ニトロセルロースシート (ワットマン社 製) を 5 mmX 2 Ommに裁断し、 その下端から 10 mmの位置にテストライン 用として各緩衝液で調製した抗 H pモノクローナル抗体 21 G 2溶液を、 15m mの位置にコントロールライン用として抗マウス I gGポリクローナル抗体 (C a p p e 1社製) (lmg/mL) を、 バイオジェット Q3000 (B i o d o t社製) を用いて線状に塗布して固相化した。 室温で 2時間乾燥後、 1%スキム ミルク (D i f c o社製) -0. 1%ツイーン 20— PB Sに 10分浸漬しマス キングを行った。 その後、 充分に乾燥した。 1 OmM buffer containing 3% methanol (sodium phosphate (pH 5-8), sodium acetate (pH 4-6), ammonium acetate ( PH 4-6), sodium tenoate (pH 4-6), tris-hydrochloride (PH7 ~ 9), sodium borate (pH8-10), ammonium chloride (pH8 ~ ll), ammonium carbonate (pH8 ~ 10)), lmg of anti-Helicobacter pylori (Hp) monoclonal antibody 21G2 / mL. A nitrocellulose sheet (manufactured by Whatman) was cut into 5 mm x 2 Omm, and an anti-Hp monoclonal antibody 21G2 solution prepared with each buffer for test lines was placed at a position 10 mm from the lower end, and a position 15 mm from the bottom. Then, an anti-mouse IgG polyclonal antibody (Cappe 1) (lmg / mL) was applied linearly using Biojet Q3000 (Biodot) as a control line to immobilize it. After drying at room temperature for 2 hours, masking was performed by immersing in 1% skim milk (manufactured by Difco) -0.1% Tween 20-PBS for 10 minutes. Then, it was sufficiently dried.
(2) 着色ラテックス粒子標識抗体の作製 (2) Preparation of colored latex particle labeled antibody
赤色ラテックス粒子分散液 (P L— L a t e x、 10%、 粒子径 450 nm、 ポリマーラボトリーズ社製) 100 /z Lを、 10000 r pm、 5分間遠心分離 を行った。 沈渣に抗 Hpモノクローナル抗体 21 G 2溶液 (lmg/mL) lm Lカロえ、 充分混和して、 室温、 1時間反応を行った。 未反応のモノクローナル抗 体を除去するため、 10000 r pm、 5分間遠心分離を行い、 沈渣を P B S 1 mLに懸濁し、 再度遠心分離を行った。 1%スキムミルク lmLを加え、 室温、 1時間反応させてマスキングを行った。 その後、 10000 r pm、 5分間遠心 分離を行い、 1%スキムミルク一 0. 01%アジ化ナトリウムを含む PB S lm Lに沈渣を懸濁した。 100 / zL of a red latex particle dispersion (PL-Latex, 10%, particle diameter 450 nm, manufactured by Polymer Laboratories) was centrifuged at 10,000 rpm for 5 minutes. An anti-Hp monoclonal antibody 21 G 2 solution (lmg / mL) was added to the precipitate, and the mixture was mixed well and reacted at room temperature for 1 hour. Unreacted monoclonal anti To remove the body, centrifugation was performed at 10,000 rpm for 5 minutes, the precipitate was suspended in 1 mL of PBS, and centrifuged again. Masking was performed by adding 1 mL of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in PBSlmL containing 1% skim milk and 0.01% sodium azide.
(3) ィムノクロマトグラフィ一試験片の作製 (3) Preparation of test piece for immunochromatography
( 1 ) で作製したそれぞれの抗体固相化支持体の下端から 2 mmの位置まで 5 mmX 1 Ommに裁断したグラスフィルター (ワットマン社製) を重ねた。 更に、 グラスフィルター上に液体試料吸収用担体 (C/P— 30、 ワットマン社製) を 下端から 2. 5 mmの位置まで重ねた。 また、 抗体固相化支持体の上端から 2 m mの位置まで吸水性担体 (3 MM Ch r、 ワットマン社製) を重ね、 最後に透 明なテープを上部に貼り固定してィムノクロマトグラフィ一試験片とした。 (4) Hp標準抗原の調製  Glass filters (manufactured by Whatman) cut to 5 mm × 1 Omm were overlapped to a position 2 mm from the lower end of each antibody-immobilized support prepared in (1). In addition, a liquid sample absorbing carrier (C / P-30, manufactured by Whatman) was stacked on the glass filter to a position 2.5 mm from the lower end. In addition, a water-absorbing carrier (3 MM Chr, manufactured by Whatman) is stacked up to 2 mm from the upper end of the antibody-immobilized support. It was a piece. (4) Preparation of Hp standard antigen
5 %ゥマ脱繊血を含むブレイン ハート インヒユージョン寒天培地 (ディフ コネ土製) 150枚にへリコパクター 'ピロリ ATCC43504株を 37°C、 4 日間、 微好気培養した。 培養後、 菌体を集め、 PB S 40mLで懸濁後、 30 00 r p m、 20分間遠心分離した。 沈渣を 0. 5 %ホルマリン含有 P B S 4 OmLに懸濁し、 4° (:、 1晚放置して不活化した。 不活化した菌体は、 PB S Helicobacter Pylori ATCC43504 strain was microaerobically cultured for 4 days at 37 ° C on 150 plates of Brain Heart Infusion Agar Medium (Diff Kone Soil) containing 5% permeabilized blood. After the culture, the cells were collected, suspended in 40 mL of PBS, and centrifuged at 300 rpm for 20 minutes. The precipitate was suspended in 4 OmL of PBS containing 0.5% formalin and inactivated by leaving it at 4 ° (:, 1 晚. The inactivated cells were PBS
4 OmLにて 3回洗浄し、 ホルマリンを除去した後、 同量の PB Sに再懸濁した。 菌液の濁度 (540 nmでの吸光度) 及ぴ総菌数 (計算盤を用いた顕微鏡観察) を確認した後、 超音波処理により破砕した。 菌体破砕物は、 3000 r pm、 2 0分間遠心分離し、 その上清を更に 30000 r pm、 30分間超遠心した。 こ の上清を 0. 2 μιηのフィルターにてろ過して Hp標準抗原とした。 After washing three times with 4 OmL to remove formalin, the cells were resuspended in the same amount of PBS. After confirming the turbidity of the bacterial solution (absorbance at 540 nm) and the total number of bacteria (microscopic observation using a calculator), the cells were disrupted by sonication. The disrupted cells were centrifuged at 3,000 rpm for 20 minutes, and the supernatant was further ultracentrifuged at 30,000 rpm for 30 minutes. The supernatant was filtered through a 0.2 μιη filter to obtain an Hp standard antigen.
(5) Hp抗原標準液の測定 (5) Measurement of Hp antigen standard solution
0. 5%B S A-0. 02%ツイーン 20 _P B Sで希釈した Hp抗原標準液 0.5% BSA-0.02% Tween 20 _PBS diluted Hp antigen standard solution
50 μ Lと、 ( 2 ) で作製した着色ラテックス粒子標識抗体液 10 μ Lとを混合 した液に ( 3 ) で得られたィムノクロマトグラフィ ^"試験片の液体試料吸収用担 体部を浸漬して展開させ、 1 0分後に目視判定をした。 その結果を表 1に示した。 「十」 はテス トラインの赤いラインを確認できること、 「土」 はテス トラインの 赤い色が確認できるが非常に色が薄いこと、 「一」 はテス トラインの赤いライン' を確認できないことを示す。 酢酸ナトリウム緩衝液 ( p H 5 ) 及ぴ酢酸アンモニ ゥム緩種 Ϊ液 ( p H 5 ) を用いてテストラインを固相化することで、 H p抗原標準 液 0 . 5 μ g /m Lまで判定可能であつた。 表 1 Mix 50 μL with 10 μL of the colored latex particle-labeled antibody solution prepared in (2). The carrier for absorbing the liquid sample of the test piece of the immunochromatography ^ "obtained in (3) was immersed and developed in the liquid thus obtained, and was visually judged after 10 minutes. The results are shown in Table 1. "Ten" indicates that the test line red line can be confirmed, "Soil" indicates that the test line red color can be confirmed but is very light, and "One" indicates that the test line red line 'cannot be confirmed. By immobilizing the test line using sodium acetate buffer (pH 5) and ammonium acetate buffer (pH 5), 0.5 μg / mL of Hp antigen standard solution was obtained. It was possible to judge up to. table 1
Hp抗原標準液 ^g/ml) Hp antigen standard solution ^ g / ml)
抗体固相化用緩龠彼  Antibody immobilization
0 0.2 0.5 1 2 5 10 リン酸 Na(pH5) + + + リン酸 Na(pH6) +  0 0.2 0.5 1 2 5 10 Na phosphate (pH5) + + + Na phosphate (pH6) +
リン酸 Na(pH7) +  Na phosphate (pH7) +
リン酸 Na(pH8) +  Na phosphate (pH8) +
酢酸 Na(pH4) 土 + + + 酢酸 Na(pH5) 土 + + + + 酢酸 Na(pH6) ± + + + 酢酸アンモニクム (pH4) 土 + + + 酢酸アンモニクム (pH5) 土 + + + + 酢酸アンモニゥム (pH6) 士 + + + クェン酸 Na(pH4) ± + + + クェン酸 Na(pH5) 土 + + + クェン酸 Na(pH6) 土 + + + ホウ酸 Na(pH8) 土 + ホウ酸 Na(pH9) 土 + ホウ酸 Na(pH10) 士 トリス塩酸 (pH7) + トリス塩酸 (pH8) + + トリス塩酸 (pH9) + + Na acetate (pH4) Soil + + + Na acetate (pH5) Soil + + + + Na acetate (pH6) ± + + + Ammonium acetate (pH4) Soil + + + Ammonium acetate (pH5) Soil + + + + Ammonium acetate ( pH6) M + + + Na citrate (pH4) ± + + + Na citrate (pH5) Sat + + + Na citrate (pH6) Sat + + + Na borate (pH 8) Sat + Na borate (pH 9) Sat + Na borate (pH 10) M Tris hydrochloric acid (pH 7) + Tris hydrochloric acid (pH 8) + + Tris hydrochloric acid (pH 9) + +
NH4OH-NH4Cl (pH8) + +NH 4 OH-NH 4 Cl (pH8) + +
NH OH-NH C 1 (pH9) + +NH OH-NH C 1 (pH9) + +
NH4OH-NH4Cl(pH10) 土 +NH 4 OH-NH 4 Cl (pH10) Sat +
NH4OH-NH4Cl(pHll) ± + 炭酸アンモニクム (pH8) + + 炭酸アンモ^ム (pH9) + + 炭酸アンモニゥム (ρΗΙΟ) 士 + (実施例 2) 着色ラテックス標識物保持担体のブロッキング溶液の比較 NH 4 OH-NH 4 Cl (pHll) ± + Ammonium carbonate (pH8) + + Ammonium carbonate (pH9) + + Ammonium carbonate (ρΗΙΟ) (Example 2) Comparison of blocking solution of carrier holding colored latex label
(1) 抗体固相化支持体の作製  (1) Preparation of antibody-immobilized support
ニトロセルロースシート (ヮットマン社製) を 5 mm X 20 mmに裁断し、 そ の下端から 1 Ommの位置にテストライン用として 3%メタノールを含む 10m M酢酸アンモニゥム (pH5) 緩衝液で調製した抗 Hpモノクローナル抗体溶液 (1 mg/mL) を、 15 mniの位置にコントロールライン用として抗マウス I g Gポリクローナル抗体 (C a p p e 1社製) (lmg/mL) をバイオジエツ ト Q3000 (B i o d o t社製) を用いて線状に塗布して固相化した。 室温で 2時間乾燥後、 1%スキムミルク (D i f c o社製) 一 0. 1%ツイーン 20— PB Sに 10分浸漬しマスキングを行った。 その後、 充分に乾燥した。  A nitrocellulose sheet (made by Petman) was cut into a size of 5 mm x 20 mm, and an anti-Hp prepared with 10 mM ammonium acetate (pH 5) buffer containing 3% methanol for the test line at a position 1 Omm from the lower end. A monoclonal antibody solution (1 mg / mL) and anti-mouse IgG polyclonal antibody (Cappe 1) (lmg / mL) (lmg / mL) as a control line at the position of 15 mni were added to BioDiet Q3000 (Biodot). It was applied linearly and solidified. After drying at room temperature for 2 hours, masking was performed by immersing in 1% skim milk (manufactured by Difco) -0.1% Tween 20-PBS for 10 minutes. Then, it was sufficiently dried.
( 2 ) 着色ラテックス標識物保持担体作製時のブロッキング溶液の比較 ポリビュルアルコール (以下 PVAとする、 和光純薬社製) 、 ポリビニノレピロ リ ドン K 15 (以下 P VPとする、 東京化成社製) 、 ツイーン 20、 トライトン X— 100、 ドデシル硫酸ナトリウム (以下 SDSとする) 、 スキムミルク、 ゥ シ血清アルブミン (以下 BS Aとする) を用いて、 着色ラテックス標識物保持用 担体であるグラスファイバーフィルターのブロッキングに及ぼす影響を調べた。 5mmX 10 mmに裁断したグラスフィルターを、 1 %濃度に調製した P VA、 PVP、 ツイーン 20、 トライ トン X— 100、 SDS、 スキムミルク、 B SA にそれぞれ 5分間浸漬し、 ブロッキングを行った。 室温、 2時間乾燥後、 実施例 1で作製した着色ラテックス粒子標識抗体を 10μ L塗布した。 その後、 充分に 乾燥し着色ラテックス標識物保持担体とした。 (2) Comparison of blocking solution when preparing a carrier holding colored latex labeled substance Polyvinyl alcohol (hereinafter referred to as PVA, manufactured by Wako Pure Chemical Industries), polyvinylinolepyrrolidone K15 (hereinafter, referred to as PVP, manufactured by Tokyo Chemical Industry), Using Tween 20, Triton X-100, sodium dodecyl sulfate (hereinafter referred to as SDS), skim milk, and serum albumin (hereinafter referred to as BSA) for blocking a glass fiber filter which is a carrier for holding colored latex label. The effects were examined. The glass filter cut to 5 mm × 10 mm was immersed in PVA, PVP, Tween 20, Triton X-100, SDS, skim milk, and BSA adjusted to a concentration of 1% for 5 minutes each to perform blocking. After drying at room temperature for 2 hours, the colored latex particle-labeled antibody prepared in Example 1 was applied in an amount of 10 μL. After that, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
(3) ィムノクロマトグラフィ一試験片の作製 (3) Preparation of test piece for immunochromatography
(1) で作製した抗体固相化支持体の下端から 2 mmの位置まで (2) で作製 したそれぞれの着色ラテックス標識抗体保持担体を重ねた。 更に、 着色ラテック ス保持担体上に液体試料吸収用担体 (CZP_30、 ワットマン社製) を下端か ら 2. 5mmの位置まで重ねた。 また、 抗体固相化支持体の上端から 2 mmの位 置まで吸水性担体 (3 MM Ch r、 ワットマン社製) を重ね、 最後に透明なテ -プを上部に貼り固定 クロマトグラフィー試験片とした The respective colored latex-labeled antibody holding carriers prepared in (2) were overlapped to a position 2 mm from the lower end of the antibody-immobilized support prepared in (1). In addition, a liquid sample absorption carrier (CZP_30, manufactured by Whatman) was placed on the colored latex holding carrier to a position 2.5 mm from the lower end. In addition, a water-absorbent carrier (3 MM Chr, manufactured by Whatman) is placed 2 mm from the upper end of the antibody-immobilized support. And fix it on the top to make a chromatographic test piece.
(4) 糞便検体中ヘリコパクター · ピロリの検出 (4) Detection of Helicobacter pylori in fecal samples
Hp陽性 5名、 Hp陰性 5名の糞便検体 0. l gを 0. 5%B SA— 0. 02 %ツイーン 20— PB S 2 mLに懸濁した。 3000 r p m、 1分間遠心分離 して夾雑物を除去し、 上清 50 Lを (4) で作製したィムノクロマトグラフィ 一試験片の液体試料吸収用担体部に滴下した。 10分後に目視判定した。 その結 果を表 2に示した。 「十」 はテストラインの赤いラインを確認できること、 「土 」 はテス トラインの赤い色が確認できるが非常に色が薄いこと、 「一」 はテスト ラインの赤いラインを確認できないこと、 「*」 は、 ラテックス標識抗体が凝集 し、 テストラインまで展開できないことを示す。 B S A又はスキムミルクによつ てブロッキングしたグラスファイバーフィルターが、 陽性検体では全例陽性、 陰 性検体では全例陰性と判定できた。 表 2  Fecal samples of 0.15 g of 5 Hp-positive and 5 Hp-negative were suspended in 2 mL of 0.5% BSA—0.02% Tween 20—PBS. The contaminants were removed by centrifugation at 3000 rpm for 1 minute, and 50 L of the supernatant was dropped onto the liquid sample absorption carrier part of the immunochromatography one test piece prepared in (4). After 10 minutes, it was visually judged. Table 2 shows the results. "Ten" indicates that the red line of the test line can be confirmed, "Sat" indicates that the red color of the test line can be confirmed but is very light, "One" indicates that the red line of the test line cannot be confirmed, "*" Indicates that the latex-labeled antibody has aggregated and cannot be expanded to the test line. Glass fiber filters blocked with BSA or skim milk could be determined as positive in all positive samples and negative in all negative samples. Table 2
Figure imgf000013_0001
Figure imgf000013_0001
(実施例 3) 液体試料吸収用担体の比較 (Example 3) Comparison of carriers for liquid sample absorption
(1) 着色ラテックス標識物保持担体の作製  (1) Preparation of carrier holding colored latex label
5mmX 10 mmに裁断したグラスフィルター 'を、 1%濃度に調製したスキム ミルクに 5分間浸漬し、 ブロッキングを行った。 室温、 2時間乾燥後、 実施例 1 で作製した着色ラテックス粒子標識抗体を 10 μ L塗布した。 その後、 充分に乾 燥し着色ラテックス標識物保持担体とした。 The glass filter ′ cut to 5 mm × 10 mm was immersed in skim milk adjusted to 1% concentration for 5 minutes to perform blocking. After drying at room temperature for 2 hours, Example 1 10 μL of the colored latex particle-labeled antibody prepared in 1) was applied. Thereafter, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
(2) 液体試料吸収用担体の比較 (2) Comparison of carriers for liquid sample absorption
実施例 2で作製した抗体固相化支持体の下端から 2 mmの位置まで (1) で作 製した着色ラテックス標識物保持担体を重ねた。 更に、 着色ラテックス標識物保 持担体上に液体試料吸収用担体として CZP— 30 (ヮットマン社製) 、 P 81 (ヮットマン社製) 、 C/DE 30 (ヮットマン社製) 、 DE 81 (ワットマン 社製) 、 GF/QA30 (ワットマン社製) を下端から 2. 5 mmの位置まで重 ねた。 また、 抗体固相化支持体の上端から 2 mmの位置まで吸水性担体 (3MM Ch r、 ヮットマン社製) を重ね、 最後に透明なテープを上部に貼り固定して ィムノクロマトグラフィー試験片とした。  The carrier holding the colored latex label produced in (1) was overlapped with a position 2 mm from the lower end of the antibody-immobilized support produced in Example 2. Further, CZP-30 (manufactured by Petman), P81 (manufactured by Petman), C / DE 30 (manufactured by Petman), DE81 (manufactured by Whatman) are used as carriers for absorbing liquid samples on the colored latex-labeled carrier. ), GF / QA30 (manufactured by Whatman) was placed up to 2.5 mm from the lower end. In addition, a water-absorbent carrier (3MM Chr, manufactured by Petman) is placed up to 2 mm from the top of the antibody-immobilized support. did.
(3) Hp抗原標準液の測定 (3) Measurement of Hp antigen standard solution
0. 5%B SA-O. 02%ツイーン 20— P B Sで希釈した Hp抗原標準液 50 Lを上記で得られたィムノクロマトグラフィ一試験片の液体試料吸収用担 体部に滴下して展開させ、 10分後に目視判定をした。 その結果を表 3に示した。 「十」 はテストラインの赤いラインを確認できること、 「土」 はテストラインの 赤い色が確認できるが非常に色が薄いこと、 「一」 はテストラインの赤いライン を確認できないことを示す。 液体試料吸収用担体として DE 81を用いると Hp 抗原濃度 0. 1 μ g/mLまで判定可能であった。 0.5% B SA-O. 02% Tween 20-50 L of Hp antigen standard solution diluted with PBS is dropped and spread on the liquid sample absorption support part of the immunono chromatography one test piece obtained above. After 10 minutes, a visual judgment was made. Table 3 shows the results. “Ten” indicates that the red line of the test line can be confirmed, “Sat” indicates that the red color of the test line can be confirmed but is very light, and “One” indicates that the red line of the test line cannot be confirmed. When DE 81 was used as a carrier for liquid sample absorption, determination was possible up to a Hp antigen concentration of 0.1 μg / mL.
表 3 Table 3
Figure imgf000015_0001
Figure imgf000015_0001
(実施例 4 ) H p検出に及ぼす便懸濁用緩衝液の組成の影響 (Example 4) Effect of composition of stool suspension buffer on Hp detection
(1) ィムノクロマトグラフィー試験片の作製  (1) Preparation of test piece for immunochromatography
実施例 2で作製した抗体固相化支持体の下端から 2 mmの位置まで実施例 3で 作製した着色ラテックス標識物保持担体を重ねた。 更に、 着色ラテックス標識物 保持担体上に液体試料吸収用担体として DE 81 (ワットマン社製) を下端から 2. 5mmの位置まで重ねた。 また、 抗体固相化支持体の上端から 2 mmの位置 まで吸水性担体 (3 MM Ch r、 ワットマン社製) を重ね、 最後に透明なテー プを上部に貼り固定してィムノクロマトグラフィー試験片とした。 (2) Hp標準抗原検出に及ぼす便懸濁用緩衝液の組成の影響  The colored latex-labeled substance holding carrier prepared in Example 3 was overlapped with a position 2 mm from the lower end of the antibody-immobilized support prepared in Example 2. Further, DE 81 (manufactured by Whatman) was superimposed on the carrier holding the colored latex label as a liquid sample absorbing carrier to a position 2.5 mm from the lower end. In addition, a water-absorbing carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support, and finally a transparent tape is stuck on top and immobilized. It was a piece. (2) Effect of stool suspension buffer composition on Hp standard antigen detection
0. 5%B S A-0. 02%ツイーン 20— PB S及ぴ 0. 5%BSA— 0. 02%ツイーン 20を含む 15 OmMの各緩衝液 (リン酸ナトリゥム (pH5〜 8) 、 ホウ酸ナトリウム (pH8〜: L 0) ) で希釈した Hp抗原標準液 50 μ L を上記で得られたィムノクロマトグラフィ一試験片の液体試料吸収用担体部に滴 下して展開させ、 10分後に目視判定をした。 その結果を表 4に示した。 「 + J はテストラインの赤いラインを確認できること、 「土」 はテストラインの赤い色 が確認できるが非常に色が薄いこと、 「一」 はテストラインの赤いラインを確認 できないことを示す。 便懸濁用緩衝液に P B S及びホウ酸ナトリゥム緩衝液を用 いると Hp抗原濃度 0. 1 μ gZmLまで正確に判定可能であった。 表 4 0.5% BS A-0. 02% Tween 20—PBS and 0.5% BSA—0.02% Tween 20 in 15 OmM buffer (sodium phosphate (pH 5-8), boric acid 50 μL of the Hp antigen standard solution diluted with sodium (pH 8: L 0)) was dropped on the carrier for liquid sample absorption of the immunochromatography-one test piece obtained above, and developed. Judged. Table 4 shows the results. "+ J indicates that the red line of the test line can be confirmed," Soil "indicates that the red color of the test line can be confirmed but is very pale, and" one "indicates that the red line of the test line cannot be confirmed. When PBS and sodium borate buffer were used as the stool suspension buffer, accurate determination was possible up to an Hp antigen concentration of 0.1 μgZmL. Table 4
Figure imgf000016_0001
Figure imgf000016_0001
(実施例 5) 抗 Hpモノクローナル抗体 82 B 9を用いたィムノクロマトグラフ ィー試験片の作製 (Example 5) Preparation of immunochromatographic test piece using anti-Hp monoclonal antibody 82B9
(1) 抗体固相化支持体の作製  (1) Preparation of antibody-immobilized support
3%メタノールを含む 1 OmMの各緩衝液 (リン酸ナトリウム (pH5〜8) 、 酢酸アンモニゥム (pH4〜6) 、 ホウ酸ナトリウム (pH8〜10) ) を調製 し、 抗ヘリコバクタ一 · ピロリ (Hp) モノクローナル抗体 82B 9を lmgZ mLの濃度に添加した。 エトロセルロースシート (ワットマン社製) を 5mmX 2 Ommに裁断し、 その下端から 1 Ommの位置にテストライン用として各緩衝 液で調製した抗 Hpモノクローナル抗体 82 B 9溶液を、 15 mmの位置にコン トロールライン用として抗マウス I gGポリクローナル抗体 (C a p p e 1社製 ) (lmg/mL) を、 バイオジエツト Q3000 (B i o d o t社製) を用い て線状に塗布して固相化した。 室温で 2時間乾燥後、 1%スキムミルク (D i f c o社製) 一0. 1%ツイーン 20— PB Sに 10分浸漬しマスキングを行った。 その後、 充分に乾燥した。 (2) 着色ラテックス粒子標識抗体の作製 Prepare 1 OmM buffer solution containing 3% methanol (sodium phosphate (pH 5-8), ammonium acetate (pH 4-6), sodium borate (pH 8-10)) and prepare anti-Helicobacter pylori (Hp) Monoclonal antibody 82B9 was added to a concentration of lmgZ mL. An Etrocellulose sheet (manufactured by Whatman) was cut into 5 mm X 2 Omm, and the anti-Hp monoclonal antibody 82B9 solution prepared with each buffer for the test line was used at a position 1 Omm from the lower end, and the solution was placed at a position 15 mm away. An anti-mouse IgG polyclonal antibody (Cappe 1) (lmg / mL) was applied linearly to a solid line by using Biojet Q3000 (Biodot) for a troll line. After drying at room temperature for 2 hours, it was immersed in 1% skim milk (manufactured by Difco) -0.1% Tween 20-PBS for 10 minutes to perform masking. Then, it was sufficiently dried. (2) Preparation of colored latex particle labeled antibody
赤色ラテックス粒子分散液 (PL— L a t e x、 10%、 粒子径 450 nm、 ポリマーラボトリーズ社製) l O O ^ Lを、 10000 r pm、 5分間遠心分離 を行った。 沈渣に抗 Hpモノクローナル抗体 82 B 9溶液 (Img/mL) 1 m L加え、 充分混和して、 室温、 1時間反応を行った。 未反応のモノクローナル抗 体を除去するため、 10000 r pm、 5分間遠心分離を行い、 沈渣を P B.S 1 mLに懸濁し、 再度遠心分離を行った。 1%スキムミルク lmLを加え、 室温、 1時間反応させてマスキングを行った。 その後、 10000 r pm、 5分間遠心 分離を行い、 1%スキムミルク一 0. 01%アジ化ナトリウムを含む PB S lm Lに沈渣を懸濁した。  Red latex particle dispersion (PL-Latex, 10%, particle diameter 450 nm, manufactured by Polymer Laboratories) lO O ^ L was centrifuged at 10,000 rpm for 5 minutes. 1 mL of anti-Hp monoclonal antibody 82B9 solution (Img / mL) was added to the precipitate, mixed well, and reacted at room temperature for 1 hour. To remove unreacted monoclonal antibody, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in 1 mL of PBS and centrifuged again. Masking was performed by adding 1 mL of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in PBSlmL containing 1% skim milk and 0.01% sodium azide.
(3) 着色ラテックス標識物保持担体の作製 (3) Preparation of carrier holding colored latex label
5mmX 10 mmに裁断したグラスフィルターを、 1 %濃度に調製したスキム ミルクに 5分間浸漬し、 ブロッキングを行った。 室温、 2時間乾燥後、 (2) で 作製した着色ラテックス粒子標識抗体を 1 塗布した。 その後、 充分に乾燥 し着色ラテックス標識物保持担体とした。  The glass filter cut to 5 mm × 10 mm was immersed in skim milk adjusted to a concentration of 1% for 5 minutes to perform blocking. After drying at room temperature for 2 hours, one of the colored latex particle-labeled antibodies prepared in (2) was applied. Thereafter, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
(4) ィムノクロマトグラフィー試験片の作製 (4) Preparation of test piece for immunochromatography
(1) で作製したそれぞれの抗体固相化支持体の下端から 2 mmの位置まで ( 3) で作製した着色ラテックス標識物保持担体を重ねた。 更に、 着色ラテックス 標識物保持担体上に液体試料吸収用担体として DE 8 1 (ヮットマン社製) を下 端から 2. 5mmの位置まで重ねた。 また、 抗体固相化支持体の上端から 2 mm の位置まで吸水性担体 (3MM Ch r、 ワットマン社製) を重ね、 最後に透明 なテープを上部に貼り固定してィムノクロマトグラフィ一試験片とした。  The colored latex label holding material prepared in (3) was superimposed on the antibody-immobilized support prepared in (1) to a position 2 mm from the lower end of the support. Further, DE81 (made by Petman) as a carrier for absorbing a liquid sample was stacked on the carrier holding the colored latex label to a position 2.5 mm from the lower end. In addition, a water-absorbing carrier (3MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support, and finally a transparent tape is attached to the top and fixed, and the immobilized chromatographic test piece is attached. did.
(5) Hp抗原標準液の測定 (5) Measurement of Hp antigen standard solution
0. 5%B S A- 0. 02%ツイーン 20を含む 1 5 OmMホウ酸ナトリウム 緩衝液 (PH8) で希釈した Hp抗原標準液 50 μ Lを上記で得られたィムノク 口マトグラフィー試験片の液体試料吸収用担体部に滴下して展開させ、 10分後 に目視判定をした。 その結果を表 5に示す。 「 +」 はテストラインの赤いライン を確認、できること、 「'土」 はテストラインの赤い色が確認できるが非常に色が薄 いこと、 「一」 はテストラインの赤いラインを確認できないことを示す。 リン酸 ナトリウム緩種 Ϊ液 (pH6) を用いてテストラインを固相化することで、 Hp抗 原濃度 0. 25 μ gZmLまで正確に判定可能であった。 表 5 Liquid of 50 μL of Hp antigen standard solution diluted with 15 OmM sodium borate buffer (PH8) containing 0.5% BS A-0.02% Tween 20 Drop on the sample-absorbing carrier and let it develop, and after 10 minutes Was visually determined. Table 5 shows the results. "+" Indicates that the test line red line can be confirmed and can be confirmed. "'Soil" indicates that the test line red color can be confirmed but is very light. "I" indicates that the test line red line cannot be confirmed. Show. By immobilizing the test line using sodium phosphate buffered saline (pH 6), it was possible to accurately determine the Hp antigen concentration up to 0.25 μgZmL. Table 5
Figure imgf000018_0001
Figure imgf000018_0001
(実施例 6) 抗 Hpモノクローナル抗体 41A5を用いたィムノクロマトグラフ ィー試験片の作製 (Example 6) Preparation of immunochromatographic test piece using anti-Hp monoclonal antibody 41A5
(1) 抗体固相化支持体の作製  (1) Preparation of antibody-immobilized support
3%メタノールを含む 1 OmMの各緩衝液 (リン酸ナトリウム (pH5〜8) 、 酢酸アンモニゥム (pH4〜6) 、 ホウ酸ナトリウム (pH8〜10) ) を調製 し、 抗ヘリコパクター · ピロリ (H ) モノクローナル抗体 41 A5を lmgZ mLの濃度に添加した。 ニトロセルロースシート (ワットマン社製) を 5mmX 2 Ommに裁断し、 その下端から 10 mmの位置にテストライン用として各緩衝 液で調製した抗 Hpモノクローナル抗体 41 A 5溶液を、 15 mmの位置にコン トロールライン用として抗マウス I g Gポリクローナル抗体 (C a p p e 1社製 ) (lmg/mL) を、 バイオジヱット Q3000 (B i o d o t社製) を用い て線状に塗布して固相化した。 室温で 2時間乾燥後、 1%スキムミルク (D i f c o社製) 一 0. 1%ツイーン 20— PB Sに 10分浸漬しマスキングを行つた c その後、 充分に乾燥した。 (2) 着色ラテックス粒子標識抗体の作製 Prepare 1 OmM buffer (sodium phosphate (pH 5-8), ammonium acetate (pH 4-6), sodium borate (pH 8-10)) containing 3% methanol, and prepare anti-Helicobacter pylori (H) monoclonal Antibody 41 A5 was added to a concentration of lmgZ mL. A nitrocellulose sheet (manufactured by Whatman) was cut into 5 mm X 2 Omm, and an anti-Hp monoclonal antibody 41A5 solution prepared with each buffer solution for a test line was used at a position 10 mm from the lower end, and a solution was added at a position 15 mm from the buffer. Using anti-mouse IgG polyclonal antibody (C appe 1) (lmg / mL) and BioJet Q3000 (Biodot) for troll line To form a solid phase. After 2 hours drying at room temperature, 1% skim milk (D ifco Co.) Single 0.1% Tween 20- PB KoTsuta c then a 10-minute immersion was masked S, and thoroughly dried. (2) Preparation of colored latex particle labeled antibody
赤色ラテックス粒子分散液 (PL— L a t e x、 10%、 粒子径 450 nm、 ポリマーラボトリーズ社製) 100 Lを、 10000 r pm、 5分間遠心分離 を行った。 沈渣に抗 Hpモノクローナル抗体 41 A 5溶液 (lmg/mL) 1 m L加え、 充分混和して、 室温、 1時間反応を行った。 未反応のモノクローナル抗 体を除去するため、 10000 r pm、 5分間遠心分離を行い、 沈渣を PB S 1 mLに懸濁し、 再度遠心分離を行った。 1%スキムミルク lmLを加え、 室温、 1時間反応させてマスキングを行った。 その後、 10000 r pra、 5分間遠心 分離を行い、 1%スキムミルク一 0. 01%アジ化ナトリウムを含む PB S lm Lに沈渣を懸濁した。  100 L of a red latex particle dispersion (PL-Latex, 10%, particle diameter 450 nm, manufactured by Polymer Laboratories) was centrifuged at 10,000 rpm for 5 minutes. 1 mL of anti-Hp monoclonal antibody 41A5 solution (lmg / mL) was added to the precipitate, mixed well, and reacted at room temperature for 1 hour. To remove unreacted monoclonal antibodies, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in 1 mL of PBS and centrifuged again. Masking was performed by adding 1 mL of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in PBS B containing 1% skim milk and 0.01% sodium azide.
(3) 着色ラテックス標識物保持担体の作製 (3) Preparation of carrier holding colored latex label
5mmX 10 mmに裁断したグラスフィルターを、 1%濃度に調製したスキム ミルクに 5分間浸漬し、 ブロッキングを行った。 室温、 2時間乾燥後、 (2) で 作製した着色ラテックス粒子標識抗体を 10 L塗布した。 その後、 充分に乾燥 し着色ラテックス標識物保持担体とした。  The glass filter cut to 5 mm × 10 mm was immersed in skim milk adjusted to 1% concentration for 5 minutes to perform blocking. After drying at room temperature for 2 hours, 10 L of the colored latex particle-labeled antibody prepared in (2) was applied. Thereafter, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
(4) ィムノクロマトグラフィー試験片の作製 (4) Preparation of test piece for immunochromatography
(1) で作製したそれぞれの抗体固相化支持体の下端から 2 mmの位置まで ( 3) で作製した着色ラテックス標識物保持担体を重ねた。 更に、 着色ラテックス 標識物保持担体上に液体試料吸収用担体として DE 8 1 (ヮットマン社製) を下 端から 2. 5mmの位置まで重ねた。 また、 抗体固相化支持体の上端から 2 mm の位置まで吸水性担体 (3 MM Ch r、 ワットマン社製) を重ね、 最後に透明 なテープを上部に貼り固定してィムノクロマトグラフィ一試験片とした。 (5) Hp抗原標準液の測定 The colored latex label holding material prepared in (3) was superimposed on the antibody-immobilized support prepared in (1) to a position 2 mm from the lower end of the support. Furthermore, DE81 (made by Petman) as a carrier for absorbing a liquid sample was superimposed on the carrier holding the colored latex label to a position 2.5 mm from the lower end. In addition, a water-absorbent carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support. And (5) Measurement of Hp antigen standard solution
0. 5%B S A- 0. 02%ツイーン 20を含む 15 OmMホウ酸ナトリウム 緩衝液 (pH8) で希釈した Hp抗原標準液 50;/ Lを上記で得られたィムノク 口マトグラフィー試験片の液体試料吸収用担体部に滴下して展開させ、 10分後 に目視判定をした。 その結果を表 5に示す。 「十」 はテストラインの赤いライン を確認できること、 「一」 はテストラインの赤いラインを確認できないことを示 す。 酢酸アンモニゥム緩衝液 (pH4及ぴ pH5) を用いてテストラインを固相 化することで、 Hp抗原濃度 0. 25 μ g/mLまで正確に判定可能であった。 表 6  0.5% BS A- 0.02% Tween 20 Hp antigen standard solution 50 / L diluted with 15 OmM sodium borate buffer (pH 8) The sample was dropped on the carrier for sample absorption and developed, and a visual judgment was made 10 minutes later. Table 5 shows the results. “10” indicates that the red line on the test line can be confirmed, and “1” indicates that the red line on the test line cannot be confirmed. By immobilizing the test line with ammonium acetate buffer (pH 4 and pH 5), it was possible to accurately determine the Hp antigen concentration up to 0.25 μg / mL. Table 6
Figure imgf000020_0001
Figure imgf000020_0001
(実施例 7) 抗 Hpモノクローナル抗体 31 A 3および抗体 21G2を用いたィ ムノクロマトグラフィー試験片の作製 (Example 7) Preparation of immunochromatographic test piece using anti-Hp monoclonal antibody 31A3 and antibody 21G2
(1) 抗体固相化支持体の作製  (1) Preparation of antibody-immobilized support
3%メタノールを含む 1 OmMの各緩衝液 (リン酸ナトリウム (pH5〜8) 、 酢酸アンモニゥム (pH4〜6) 、 ホウ酸ナトリウム (pH8〜10) ) を調製 し、 抗ヘリコパクター ' ピロリ (H ) モノクローナル抗体 31A3を lmgZ m lの濃度に添加した。 ニトロセルロースシート (ワットマン社製) を 5mmx 2 Ommに裁断し、 その下端から 1 Ommの位置にテストライン用として各緩衝 液で調製した抗 Hpモノクローナル抗体溶液を、 1 5 mmの位置にコントロール ライン用として抗マウス I gGポリクローナル抗体 (Ca p p e 1社製) (1 m g/m 1 ) を、 バイオジェット Q3000 (B i o d o t社製) を用いて線状に 塗布して固相化した。 室温で 2時間乾燥後、 1%スキムミルク (D i f c o社製 ) -0. 1 %ツイーン 20— ; PB Sに 10分浸漬しマスキングを行った。 その後、 充分に乾燥した。 Prepare 1 OmM buffer solution containing 3% methanol (sodium phosphate (pH 5-8), ammonium acetate (pH 4-6), sodium borate (pH 8-10)) and prepare anti-helicopter pylori (H) monoclonal Antibody 31A3 was added to a concentration of lmgZ ml. Nitrocellulose sheet (made by Whatman) is cut into 5mm x 2 Omm, and each buffer is placed at 1 Omm from the lower end for the test line. The anti-Hp monoclonal antibody solution prepared in the above solution was placed at a position of 15 mm, and an anti-mouse IgG polyclonal antibody (manufactured by Cappe 1) (1 mg / m 1) was used as a control line for Biojet Q3000 (Biodot). Was applied linearly to make a solid phase. After drying at room temperature for 2 hours, masking was performed by immersing in 1% skim milk (manufactured by Difco) -0.1% Tween 20-; PBS for 10 minutes. Then, it was sufficiently dried.
(2) ィムノクロマトグラフィー試験片の作製 (2) Preparation of test piece for immunochromatography
(1) で作製したそれぞれの抗体固相化支持体の下端から 2 mmの位置まで実 施例 3 ( 1 ) で作製した抗体 21 G 2着色ラテックス標識物保持担体を重ねた。 更に、 着色ラテツクス標識物保持担体上に液体試料吸収用担体として D E 81 ( ワットマン社製) を下端から 2. 5mmの位置まで重ねた。 また、 抗体固相化支 持体の上端から 2 mmの位置まで吸水性担体 ( 3 MM C h r、 ワットマン社製 ) を重ね、 最後に透明なテープを上部に貼り固定してィムノクロマトグラフィー 試験片とした。  The carrier holding the antibody 21G2 colored latex labeling substance prepared in Example 3 (1) was overlapped to a position 2 mm from the lower end of each of the antibody-immobilized supports prepared in (1). Further, DE 81 (manufactured by Whatman) as a carrier for absorbing a liquid sample was overlaid on the carrier holding the colored latex label to a position 2.5 mm from the lower end. In addition, a water-absorbing carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support. It was a piece.
(3) Hp抗原標準液の測定 (3) Measurement of Hp antigen standard solution
0. 5%B S A- 0. 02%ツイーン 20を含む 1 5 OmMホウ酸ナトリウム 緩衝液 (pH8) で希釈した Hp抗原標準液 50 / Lを上記で得られたィムノク 口マトグラフィー試験片の液体試料吸収用担体部に滴下して展開させ、 10分後 に目視判定をした。 その結果を表 7に示す。 「十」 はテストラインの赤いライン を確認できること、 「土」 はテストラインの赤い色が確認できるが非常に色が薄 いこと、 「一」 はテストラインの赤いラインを確認できないことを示す。 リン酸 ナトリウム緩衝液 (pH7) を用いてテストラインを固相化することで、 Hp抗 原濃度 0. 25 μ g/m 1まで正確に判定可能であった。 表 7 0.5% BS A- 0.02% Tween 20 containing 15 OmM sodium borate buffer (pH 8) diluted with 50 / L Hp antigen standard solution The sample was dropped on the carrier for sample absorption and developed, and a visual judgment was made 10 minutes later. Table 7 shows the results. “Ten” indicates that the red line of the test line can be confirmed, “Sat” indicates that the red color of the test line can be confirmed but is very pale, and “One” indicates that the red line of the test line cannot be confirmed. By immobilizing the test line using sodium phosphate buffer (pH 7), it was possible to accurately determine the Hp antigen concentration up to 0.25 μg / ml. Table 7
Figure imgf000022_0001
Figure imgf000022_0001
(実施例 8) 抗 Hpモノクローナル抗体 82 A3を用いたィムノクロマトグラフ ィー試験片の作製 (Example 8) Preparation of immunochromatographic test piece using anti-Hp monoclonal antibody 82A3
(1) 抗体固相化支持体の作製  (1) Preparation of antibody-immobilized support
3%メタノールを含む 1 OmMの各緩衝液 (リン酸ナトリウム (pH5〜8) 、 酢酸アンモニゥム (pH4〜6) 、 ホウ酸ナトリウム (pH8〜10) ) を調製 し、 抗ヘリコパクター ' ピロリ (H ) モノクローナル抗体 82A3を Img, in 1の濃度に添加した。 ニトロセルロースシート (ワットマン社製) を 5mmx 2 Ommに裁断し、 その下端から 1 Ommの位置にテストライン用として各緩衝 液で調製した抗 Hpモノクローナル抗体溶液を、 1 5 mmの位置にコントロール ライン用として抗マウス I gGポリクローナル抗体 (C a p p e 1社製) (lm g/m 1 ) を、 パイオジェット Q3000 (B i o d o t社製) を用いて線状に 塗布して固相化した。 室温で 2時間乾燥後、 1%スキムミルク (D i f c o社製 ) —0. 1 %ツイーン 20— PB Sに 10分浸漬しマスキングを行った。 その後、 充分に乾燥した。 Prepare 1 OmM buffer solution containing 3% methanol (sodium phosphate (pH 5-8), ammonium acetate (pH 4-6), sodium borate (pH 8-10)) and prepare anti-helicopter pylori (H) monoclonal Antibody 82A3 was added to a concentration of Img, in 1. A nitrocellulose sheet (manufactured by Whatman) is cut into 5 mm x 2 Omm, and the anti-Hp monoclonal antibody solution prepared with each buffer for the test line is placed at 1 Omm from the lower end, and the control line is placed at 15 mm from the lower end. An anti-mouse IgG polyclonal antibody (C appe 1) (lm g / m 1) was applied linearly using a BioJet Q3000 (Biodot) to solidify it. After drying at room temperature for 2 hours, 1% skim milk (Difco ) —0.1% Tween 20—Passed for 10 minutes and masked. Then, it was sufficiently dried.
(2) 着色ラテックス粒子標識抗体の作製 (2) Preparation of colored latex particle labeled antibody
赤色ラテックス粒子分散液 (PL— L a t e s:、 1 0 %、 粒子径 450 n m、 ポリマーラボトリーズ社製) l O O ^ Lを、 10000 r pm、 5分間遠心分離 を行った。 沈渣に抗 Hpモノクローナル抗体 82 A 3溶液 (lmg/m l) 1 m 1加え、 充分混和して、 室温、 1時間反応を行った。 未反応のモノクローナル抗 体を除去するため、 10000 r pm、 5分間遠心分離を行い、 沈渣を PB S 1 m 1に懸濁し、 再度遠心分離を行った。 1 %スキムミルク 1 m 1を加え、 室温、 1時間反応させてマスキングを行った。 その後、 10000 r pm、 5分間遠心 分離を行い、 1%スキムミルク一 0. 01 %アジ化ナトリウムを含む PB S Ira 1に沈渣を懸濁した。 (3) 着色ラテックス標識物保持担体の作製  Red latex particle dispersion (PL-Late: 10%, particle diameter 450 nm, manufactured by Polymer Laboratories) lO O ^ L was centrifuged at 10,000 rpm for 5 minutes. 1 ml of anti-Hp monoclonal antibody 82A3 solution (lmg / ml) was added to the precipitate, mixed well, and reacted at room temperature for 1 hour. To remove unreacted monoclonal antibodies, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in 1 ml of PBS and centrifuged again. Masking was performed by adding 1 ml of 1% skim milk and reacting at room temperature for 1 hour. Thereafter, centrifugation was performed at 10,000 rpm for 5 minutes, and the precipitate was suspended in PBS Ira 1 containing 1% skim milk and 0.01% sodium azide. (3) Preparation of carrier holding colored latex label
5mm l 0 mmに裁断したグラスフィルターを、 1%濃度に調製したスキム ミルクに 5分間浸漬し、 ブロッキングを行った。 室温、 2時間乾燥後、 (2) で 作製した着色ラテックス粒子標識抗体を 10 Z L塗布した。 その後、 充分に乾燥 し着色ラテックス標識物保持担体とした。  The glass filter cut to 5 mm 10 mm was immersed in skim milk adjusted to 1% concentration for 5 minutes to perform blocking. After drying at room temperature for 2 hours, the colored latex particle-labeled antibody prepared in (2) was applied in an amount of 10 ZL. Thereafter, it was sufficiently dried to obtain a colored latex labeled substance holding carrier.
(4) ィムノクロマトグラフィー試験片の作製 (4) Preparation of test piece for immunochromatography
(1) で作製したそれぞれの抗体固相化支持体の下端から 2 mmの位置まで ( 3) で作製した着色ラテックス標識物保持担体を重ねた。 更に、 着色ラテックス 標識物保持担体上に液体試料吸収用担体として DE 8 1 (ワッ トマン社製) を下 端から 2. 5 mmの位置まで重ねた。 また、 抗体固相化支持体の上端から 2 mm の位置まで吸水性担体 (3 MM Ch r、 ワットマン社製) を重ね、 最後に透明 なテープを上部に貼り固定してィムノクロマトグラフィ一試験片とした。  The colored latex label holding material prepared in (3) was superimposed on the antibody-immobilized support prepared in (1) to a position 2 mm from the lower end of the support. Furthermore, DE81 (manufactured by Wattman) as a carrier for absorbing a liquid sample was overlaid on the carrier holding the colored latex label to a position 2.5 mm from the lower end. In addition, a water-absorbent carrier (3 MM Chr, manufactured by Whatman) is placed up to 2 mm from the upper end of the antibody-immobilized support. And
(5) Hp抗原標準液の測定 0. 5%B SA-0. 02%ツイーン 20を含む 1 5 OmMホウ酸ナトリウム 緩衝液 (pH8) で希釈した H p抗原標準液 50 Lを上記で得られたィムノク 口マトグラフィー試験片の液体試料吸収用担体部に滴下して展開させ、 10分後 に目視判定をした。 その結果を表 8に示す。 「十」 はテストラインの赤いライン を確認できること、 「士」 はテス トラインの赤い色が確認できるが非常に色が薄 いこと、 「一」 はテス トラインの赤いラインを確認できないことを示す。 酢酸ァ ンモニゥム緩衝液 (pH4) を用いてテス トラインを固相化することで、 Hp抗 原濃度 0. 5 μ g/m 1まで正確に判定可能であった。 表 8 (5) Measurement of Hp antigen standard solution 0.5% B SA-0.02% Tween 20 containing 15 L of Hp antigen standard solution diluted with 15 OmM sodium borate buffer (pH 8) The sample was dropped on the carrier for sample absorption and developed, and a visual judgment was made 10 minutes later. Table 8 shows the results. “Ten” indicates that the red line on the test line can be confirmed, “Shi” indicates that the red color of the test line can be confirmed but is very light, and “One” indicates that the red line of the test line cannot be confirmed. By immobilizing the test line with ammonium acetate buffer (pH 4), it was possible to accurately determine the Hp antigen concentration up to 0.5 μg / ml. Table 8
Figure imgf000024_0001
Figure imgf000024_0001
(実施例 9) ィムノクロマトグラフィーによる糞便検体中 Hpの検出 (Example 9) Detection of Hp in fecal samples by immunochromatography
尿素呼気試験により H p陽性者及び陰性者と判定された各 10名の糞便検体 5 Omgを実施例 4で示した 1 5 OmMホウ酸ナトリウム (pH8) を用いる便懸 濁用緩衝液 lmLに懸濁した。 便懸濁液 50 を、 実施例 3 (液体試料吸収用 担体として D E 81を使用) 、 実施例 5、 実施例 6、 実施例 7、 実施例 8で作製 した各ィムノク口マトグラフィ一試験片の液体試料吸収用担体に滴下した。 10 分後にテストラインの赤いラインの有無を目視判定した。 その結果、 いずれの試 験片においても、 陽性検体では、 全 10例とも赤いラインが確認でき、 陽性と判 定された。 一方、 陰性検体では、 全 10例とも赤いラインは確認できず、 陰性と 判定された。 なお、 コントロールラインは全検体で確認できた。 これらの検体を メリディアン社製の H p SA EL I SA (ポリクローナル抗体を使用した糞便 中 Hp抗原検出酵素免疫測定キット) を用いて、 添付文書に従って試験した結果、 陽性検体は全て陽性と判定された。 しかし、 陰性検体 10例の内、 2例は陽性と 判定され、 偽陽性率が 20 %であつた。 実施例 10 ィムノクロマトグラフィーによる糞便検体中 Hpの検出 A stool suspension using 15 OmM sodium borate (pH 8) shown in Example 4 was obtained by using 5 Omg of stool specimens of each of 10 subjects determined as Hp positive and negative by the urea breath test. The suspension was suspended in 1 mL of a turbidity buffer. The stool suspension 50 was used as the liquid for each test specimen prepared in Example 3 (using DE 81 as a carrier for liquid sample absorption), Example 5, Example 6, Example 7, and Example 8. The solution was dropped onto the sample absorbing carrier. Ten minutes later, the presence or absence of a red line on the test line was visually determined. As a result, in all of the test specimens, a red line was confirmed in all of the 10 positive specimens, and the specimen was determined to be positive. On the other hand, in all of the negative samples, no red line could be confirmed in all 10 cases, and it was determined to be negative. The control line was confirmed for all samples. These samples were tested using Meridian's HpSAELISA (fecal Hp antigen detection enzyme immunoassay kit using polyclonal antibodies) according to the package insert, and all positive samples were determined to be positive. . However, of the 10 negative samples, 2 were determined to be positive, with a false positive rate of 20%. Example 10 Detection of Hp in fecal samples by immunochromatography
尿素呼気試験により判定された Hp陽性者 66名及ぴ陰性者 12名の糞便検体 5 Omgを実施例 4で示した PB Sを用いる便懸濁用緩衝液 lmLに懸濁した。 便懸濁液 50 Lを、 実施例 3で作製したィムノクロマトグラフィ一試験片 (液 体試料吸収用担体として DE 81を使用) の液体試料吸収用担体に滴下した。 1 0分後にテストラインの赤いラインの有無を目視判定した。 その結果、 陽性検体 全 66例とも赤いラインが確認でき、 陽性と判定された。 一方、 陰性検体では、 全 1 2例とも赤いラインは確認できず、 陰性と判定され、 一致率 100%であった。 なお、 コント口ールラインは全検体で確認できた。 実施例 1 1 臨床分離 H p株に対する反応性の検討  A fecal sample (5 Omg) of 66 Hp-positive persons and 12 negative persons determined by the urea breath test was suspended in 1 mL of the stool suspension buffer using PBS shown in Example 4. 50 L of the stool suspension was dropped onto the liquid sample-absorbing carrier of the immunochromatography one test piece (DE 81 was used as the liquid sample-absorbing carrier) prepared in Example 3. After 10 minutes, the presence or absence of a red line on the test line was visually determined. As a result, a red line was confirmed in all 66 positive samples, and it was determined to be positive. On the other hand, in the negative samples, no red line was observed in all of the 12 cases, and the sample was judged to be negative and the concordance rate was 100%. The control line was confirmed for all samples. Example 11 Investigation of reactivity to clinically isolated Hp strain
臨床から分離した Hp株 120株に対する反応性を検討した。 実施例 1に記載 したのと同様の方法により各菌株を培養して菌体を集め、 菌体を超音波処理する ことで Hp抗原を調製した。 0. 5%B SA— 0. 02%ツイーン 20を含む 1 5 OmMホウ酸ナトリウム緩衝液 (pH8) で 0. 25 Zm Lに希釈した H p抗原液 50 μ Lを実施例 3で作製したィムノクロマトグラフィ一試験片 (液体 試料吸収用担体として DE 8 1を使用) の液体試料吸収用担体に滴下した。 10 分後にテストラインの赤いラインの有無を目視判定した。 その結果、 臨床分離 H p株全 1 2 0株とも赤いラインを確認でき、 陽性と判定した。 なお、 コントロー ルラインは全検体で確認できた。 実施例 1 2 他の菌株に対する反応性 The reactivity with 120 Hp strains isolated from the clinic was examined. Each strain was cultured in the same manner as described in Example 1 to collect cells, and the cells were sonicated to prepare Hp antigen. 0.5% BSA—50 μL of Hp antigen solution diluted to 0.25 ZmL with 15 OmM sodium borate buffer (pH 8) containing 0.02% Tween 20 was prepared in Example 3. A drop was dropped onto a liquid sample absorbing carrier of a munochromatographic test piece (DE81 was used as a liquid sample absorbing carrier). Ten After one minute, the presence or absence of a red line on the test line was visually determined. As a result, a red line was confirmed in all of the 120 clinically isolated Hp strains, and it was determined to be positive. The control line was confirmed for all samples. Example 1 2 Reactivity to other strains
Helicobacter hepaticus ATCC51448株、 Helicobacter felis ATCC49179株、 Heli cobacter mustelae ATCC43772株、 Helicobacter cinaedi ATCC35683株、 Escheric hia coli ATCC25922株、 Campylobacter jejuni ATCC29428株、 Bacteroides vulga tus IFO 14291株、 Bifidobacterium infantis JCM1222株おょぴ 5z Jo cten'wm bre ve JCM1192株に対する反応性を検討した。 菌体を超音波処理することで菌体破 砕物を得た。 0 . 5 % B S A— 0 . 0 2 %ツイーン 2 0を含む 1 5 O mMホウ酸 ナトリウム緩衝液 ( p H 8 ) でタンパク質濃度 1 O g Zin Lに希釈した各菌体 破碎物 5 0 μ Lを実施例 3で作製したィムノクロマトグラフィ一試験片 (液体試 料吸収用担体として D E 8 1を使用) の液体試料吸収用担体に滴下した。 1 0分 後にテストラインの赤いラインの有無を目視判定した。 その結果、 全ての菌株で 赤いラインを確認せず、 陰性と判定した。 なお、 コントロールラインは全検体で 確認できた。 産業上の利用可能性  Helicobacter hepaticus ATCC51448, Helicobacter felis ATCC49179, Helicobacter mustelae ATCC43772, Helicobacter cinaedi ATCC35683, Escheric hia coli ATCC25922, Campylobacter jejuni ATCC29428, Bacteroides vulga tus IFO 14291, Bifidobacterium Josten The reactivity to wm bre ve JCM1192 strain was examined. The cells were sonicated to obtain crushed cells. 0.5% BSA — 0.02% Tween 20 15 μL of each cell lysate diluted with 15 OmM sodium borate buffer (pH 8) to a protein concentration of 1 Og Zin L Was dropped onto the liquid sample absorption carrier of the immunochromatography one test piece (DE81 used as a liquid sample absorption carrier) prepared in Example 3. After 10 minutes, the presence or absence of a red line on the test line was visually determined. As a result, no red line was confirmed in all strains, and the strain was determined to be negative. The control line was confirmed for all samples. Industrial applicability
本発明は、 上述の構成よりなるので、 糞便を検体として用い、 感度よくへリコ パクター ·ピロリへの感染を判定することができるィムノクロマトグラフィ一試 験片及び診断キットを提供することができる。  Since the present invention has the above-described configuration, it is possible to provide an immunochromatography-one test strip and a diagnostic kit that can determine infection to Helicobacter pylori with high sensitivity using feces as a specimen.

Claims

請求の範囲 The scope of the claims
1 . 短冊形状の抗体固相化支持体の下端上に下から順に着色ラテックス標識物 保持担体、 及び、 濾紙からなる液体試料吸収用担体が積層され、 一方、 前記抗体 固相化支持体の上端上に濾紙よりなる吸水性担体が積層されてなる積層体からな るィムノクロマトグラフィー試験片であって、 1. A carrier for holding a colored latex label and a carrier for absorbing a liquid sample composed of filter paper are laminated in order from the bottom on the lower end of the strip-shaped antibody-immobilized support, while the upper end of the antibody-immobilized support is An immunochromatographic test piece consisting of a laminate obtained by laminating a water-absorbing carrier made of filter paper thereon,
前記抗体固相化支持体は、 ニトロセルロースシート上にヘリコパクター · ピロリ のネイティブなカタラーゼと抗原抗体反応を行うモノクローナル抗体が固相化さ れてなり、 The antibody-immobilized support is obtained by immobilizing a monoclonal antibody that performs an antigen-antibody reaction with native Helicobacter pylori catalase on a nitrocellulose sheet,
前記着色ラテックス粒子標識物保持担体は、 着色ラテックス粒子にヘリコバクタ 一' ピロリのネイティブな力タラーゼと抗原抗体反応を行うモノクローナル抗体 を固定化してなる着色ラテックス粒子標識抗ヘリコパクター · ピロリ抗体が不織 布に含浸されてなる The colored latex particle-labeled substance holding carrier is a non-woven cloth containing a colored latex particle-labeled anti-Helicobacter pylori antibody obtained by immobilizing a monoclonal antibody that performs an antigen-antibody reaction with a native helicobacter 1 'pylori force tarase on the colored latex particles. Become impregnated
ことを特徴とするィムノクロマトグラフィー試験片。 An immunochromatographic test strip, characterized in that:
2 . 抗体固相化支持体へのへリコパクター · ピロリのネイティブなカタラーゼ と抗原抗体反応を行うモノクローナル抗体の固相化は、 酢酸ナトリゥム緩衝液、 酢酸ァンモユウム緩衝液及びリン酸ナトリゥム緩衝液からなる群より選ばれる少 なくとも 1種の緩衝液に、 ヘリコパクター · ピロリのネイティブなカタラーゼと 抗原抗体反応を行うモノクローナル抗体を分散させ、 得られた分散液をニトロセ ルロースシートに塗布することによることを特徴とする請求の範囲第 1項記載の ィムノク口マトグラフィー試験片。 2. Immobilization of monoclonal antibody that performs antigen-antibody reaction with native Helicobacter pylori catalase on an antibody-immobilized support consists of sodium acetate buffer, ammonium acetate buffer, and sodium phosphate buffer. A monoclonal antibody that performs an antigen-antibody reaction with Helicobacter pylori's native catalase is dispersed in at least one buffer selected from the group consisting of the following components, and the resulting dispersion is applied to a nitrocellulose sheet. The test specimen according to claim 1, wherein
3 . 着色ラテックス粒子標識物保持担体は、 スキムミルク又はゥシ血清アルブ ミンでブロッキングされてなることを特徴とするィムノクロマトグラフィー試験 片。 3. An immunochromatographic test strip characterized in that the carrier for holding labeled colored latex particles is blocked with skim milk or pepsin albumin.
4 . 液体試料吸収用担体は、 酸性物質吸着能を保持していることを特徴とする ィムノクロマトグラフィ一試験片。 4. A test piece for immunochromatography, wherein the carrier for absorbing a liquid sample retains the ability to adsorb acidic substances.
5. 請求の範囲第 1、 2、 3又は 4項記載のィムノクロマトグラフィー試験片 を含むことを特徴とする診断キット。 5. A diagnostic kit comprising the immunochromatographic test strip according to claim 1, 2, 3, or 4.
6. 更に、 PBS及び Z又はホウ酸ナトリウム緩衝液よりなる便懸濁用緩衝液 を含むことを特徴とする請求の範囲第 5項記載の診断キット。 6. The diagnostic kit according to claim 5, further comprising a stool suspension buffer consisting of PBS and Z or sodium borate buffer.
PCT/JP2002/004011 2001-04-23 2002-04-23 Immunochromatographic test piece and diagnosis kit WO2002088737A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002585986A JP4443117B2 (en) 2001-04-23 2002-04-23 Immunochromatographic specimen and diagnostic kit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-124885 2001-04-23
JP2001124885 2001-04-23

Publications (1)

Publication Number Publication Date
WO2002088737A1 true WO2002088737A1 (en) 2002-11-07

Family

ID=18974193

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/004011 WO2002088737A1 (en) 2001-04-23 2002-04-23 Immunochromatographic test piece and diagnosis kit

Country Status (2)

Country Link
JP (1) JP4443117B2 (en)
WO (1) WO2002088737A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106290855A (en) * 2015-06-01 2017-01-04 上海凯创生物技术有限公司 A kind of pylori antigen near-infrared fluorescent detection kit and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501817A (en) * 1984-04-02 1986-08-28 ダ−ルグレイン,エイリク Enzyme paper for displaying cholinesterase inhibitors, method for producing the same, and method for displaying substances that inhibit enzyme reactions
JPH08511282A (en) * 1994-04-08 1996-11-26 パストゥール メリユ セリュム エ ヴァサン Anti-Helicobacter pylori immune composition based on catalase
JPH1010128A (en) * 1996-05-09 1998-01-16 Meridian Diagnostics Inc Immunoassay of h. pyloric bacterium in excrement sample
JPH10185920A (en) * 1996-12-20 1998-07-14 Nippon Kayaku Co Ltd Assaying apparatus and assaying method using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501817A (en) * 1984-04-02 1986-08-28 ダ−ルグレイン,エイリク Enzyme paper for displaying cholinesterase inhibitors, method for producing the same, and method for displaying substances that inhibit enzyme reactions
JPH08511282A (en) * 1994-04-08 1996-11-26 パストゥール メリユ セリュム エ ヴァサン Anti-Helicobacter pylori immune composition based on catalase
JPH1010128A (en) * 1996-05-09 1998-01-16 Meridian Diagnostics Inc Immunoassay of h. pyloric bacterium in excrement sample
JPH10185920A (en) * 1996-12-20 1998-07-14 Nippon Kayaku Co Ltd Assaying apparatus and assaying method using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YUICHIRO KAMISHIMA: "Helicobacter pylori kansen byotai no okeru kesseiko helicobacter pylori catalasa kotaui no sonzai igi", HOKKAIDO IGAKU ZASSHI, vol. 75, no. 5, 2000, pages 287 - 298, XP002953593 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106290855A (en) * 2015-06-01 2017-01-04 上海凯创生物技术有限公司 A kind of pylori antigen near-infrared fluorescent detection kit and application thereof

Also Published As

Publication number Publication date
JPWO2002088737A1 (en) 2004-08-19
JP4443117B2 (en) 2010-03-31

Similar Documents

Publication Publication Date Title
EP2985349A1 (en) Device for detection of analytes
US20070037296A1 (en) Combined chemical and immunochemical fecal occult blood test
JP2004529350A (en) Candida Detection
US5155022A (en) Assay for lyme disease
JPS63229367A (en) Immuno-reactive reagent, manufacture thereof and application thereof for measuring immuno-reactive specy
JPH09500961A (en) Method and apparatus for simultaneous immunoassay
WO2006073153A1 (en) Simplified assay method for detecting multiple subjects
JP4268358B2 (en) Antibody and immunological assay
WO2006043614A1 (en) Membrane immunoassay method
WO1997023781A1 (en) Fecal test method and device
CA2472230A1 (en) Diagnosis of helicobacter pylori with surface plasmon resonance
AU2078495A (en) Detection of analytes
WO2002088737A1 (en) Immunochromatographic test piece and diagnosis kit
JP4122419B2 (en) Method for detection of Helicobacter pylori and hailmani in stool, saliva samples and biopsy materials
EP3967772A1 (en) Tools &amp; methods usefool for detection of lactose intolerance and uses thereof
JP4269006B2 (en) Mycobacterium tuberculosis detection method
Kuo et al. Evaluation of urine ELISA test for detecting Helicobacter pylori infection in Taiwan: a prospective study
JP2007316078A (en) Detecting method for tubercle bacillus
JP2004524522A (en) Method for detecting pancreatic and gastrointestinal diseases
WO2015093439A1 (en) Method for detecting helicobacter pylori
JP3869556B2 (en) Helicobacter pylori-derived antigen and method for diagnosing Helicobacter pylori infection using the same
JP4478658B2 (en) Mycobacterium tuberculosis detection kit
CN111190017B (en) Sensitization blocking buffer solution and application thereof
JP2000131319A (en) Method and kit for easily inspecting antibody
JP3544968B2 (en) Human hemoglobin detector

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002585986

Country of ref document: JP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase